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Abstract
Background and objectives
The Catalan Arthroplasty Register (RACat, for its acronym in Catalan) is a population-based 
register designed to assess the clinical effectiveness of hip and knee arthroplasties in Catalonia. 
The objectives of this report are 1) to present the results corresponding to the period 2005-
2014, in terms of volume, completness and quality of the information, as well as the temporary 
evolution of the arthroplasties and the variability per centre; 2) to describe the characteristics 
of patients undergoing a knee or hip arthroplasty, along with fixation techniques, models, and 
characteristics of the implants; and 3) to analyse the survival of knee and hip prosthesis in the 
short(at 1 year), mid- (at 5 years), and long-term (at 9 years).
Methodology
The RACat population comprises all insured citizens by Catalan Health Service (CatSalut) who 
underwent hip or knee arthroplasty in a healthcare centre run by the Integrated Healthcare Sys-
tem of Public Healthcare Network of Catalonia (SISCAT, for its acronym in Catalan). The current 
report covers the period between January 2005 and December 2014. During this period 53 of 
61 centres participated in a voluntary basis, sending data to the RACat. By using a secure plat-
form integrated in the Health Registers platform (RSA) of the CatSalut, hospitals sent data on 
patients, implants, interventions and surgical techniques. This information is complemented 
with data from the Central Register of Insured Persons (RCA, for its acronym in Catalan), which 
provides information on the patient’s date of birth, place of residence, and vital status. Then, 
data is linked to the Minimum Basic Data Set at Hospital Discharge (MBDSHD) and the pros-
thesis catalogue. A descriptive analysis of the volume of arthroplasties included in the RACat 
per year and period (2005-2006; 2007-2008; 2009-2010; 2011-2012; 2013-2014), hospital, and 
healthcare region was carried out. The completeness of the RACat data was calculated per year 
and was compared against participating centres by means of a funnel plot. To assess the qual-
ity of the data we computed the percentage of primary knee and hip arthroplasties that were 
identified following the classification system used in the RACat and the percentage of cases 
sent to the RACat with the operated side informed. The characteristics of patients (sex, age, 
reason for surgery, comorbidities), the characteristics of the arthroplasties (type of arthroplasty, 
fixation technique, friction device) and the most frequently used models, were all described. The 
cumulative revision rate for knee and hip arthroplasties was estimated for partial and total pro-
cedures, by type of fixation and per type of arthroplasty, and by different time intervals: 0 to 30 
days, 30 to 90 days, 90 days to 1 year, 1 to 3 years, 3 to 5 years, 5 to 7 years and 7 to 9 years. 
Cox proportional-hazard regression models were fitted to explore the effects of different factors 
in the revision arthroplasties adjusted by different covariates.
Results
Knee arthroplasties
• During 2005-2014, the RACat recorded a total of 60,192 primary knee arthroplasties 
and 6,689 revision knee arthroplasties. The highest completeness was reached in 2011, 
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showing a slight decrease over the latter period, coinciding with technical changes in 
data notification. In the latter period (2013-2014), the percentage of arthroplasties that 
were classified was 81.9% and the percentage of those with reported laterality available 
was 99.9%. 
• In the time period spanning between 2013 and 2014, the mean age of patients undergoing 
a total and partial knee arthroplasty was 72.3 and 66.8 years, respectively. Osteoarthritis 
was the main reason for intervention both for total and partial procedures (98.7% and 
96.9%, respectively) and mechanical complications were the main cause for revision 
both for total and partial knee arthroplasties.  
• Total knee procedures represented 97.0% of knee arthroplasties, whereas partial knee 
arthroplasties accounted for 3.0%. Within total knee arthroplasties, the most common 
arthroplasties were the ones that preserve the posterior cruciate retaining (CR) and 
the posterior stabilized ones (PS), representing 46.0% and 51.7%, respectively. Among 
partial knee procedures, unicompartmental arthroplasties were the most common type 
(82.9%). A 75.7% and 81.5% of total and partial knee arthroplasties were cemented, 
with a similar distribution per periods, sex, and age groups. 
• During 2005-2014, a total of 137 models (counting separately the cemented and 
cementless models) were identified. The number of models used by the participating 
hospitals ranged from 1 to 38, with an average of 12 models per hospital. 
• The cumulative revision rate for total knee arthroplasties was 0.98%, 3.84% and 5.17% 
at 1-, 5- and 9-years follow-up, respectively, whereas the cumulative revision rate for 
partial knee arthroplasties was 2.07% at 1-year and 10.24% at 5-years follow-up.  For 
total knee arthroplasties, an increased risk of revision for patients under 65 years and for 
patients aged between 65 and 75 years compared to those aged 85 years or over was 
observed (HR=3.34 (IC95%: 1.96-5.70); HR=2.02 (IC95%: 1.19-3.43), respectively).
Hip arthroplasties
• During 2005-2014, the RACat recorded a total of 46,488 primary hip arthroplasties 
and 5,237 revision hip arthroplasties. The highest completeness was reached in 2011, 
showing a slight decrease over the latter period. In the last period (2013-2014), the 
percentage of arthroplasties classified was 77.1% and the percentage of those with 
reported laterality was 97.6%.
• In the 2013-2014 time period, the mean age of patients undergoing a total and partial 
hip arthroplasty was 68.5 and 84.4 years, respectively. Osteoarthritis was the main 
reason for intervention for total procedures (81.7%), whereas fracture was the reason 
for intervention in 95.6% of partial procedures. Mechanical complications were the main 
cause for revision both for total and partial hip arthroplasties.  
• Total hip procedures represented 77.6% of hip arthroplasties, whereas partial procedures 
accounted for 22.4%. Over 95% of total hip arthroplasties were total conventional 
implants. Within partial hip arthroplasties, bipolar and unipolar monoblok were the 
most common types, representing a 46.7% and 47.2%, respectively. The proportion 
on cementless arthroplasties was 64.4% and 50.5% in total and partial hip procedures, 
respectively. In conventional total hip arthroplasties, the most commonly used friction 
device was metal-polyethylene (65.8%). Small heads (<32mm) were commonly used 
among metal-polyethylene, ceramic-polyethylene, and metal-metal implants (72.7%, 
68.1% and 43.3%, respectively). Medium heads (32-36mm) were mostly common 
among ceramic-ceramic arthroplasties (71%).
• During 2005-2014, 1,114 models of stem-socked combinations were identified. The 
number of acetabular models used by the hospitals ranged from 1 to 34, with an average 
of 16 per hospital. As for stem models, the number ranged from 1 to 33 with an average 
of 15 models per hospital.
13
• The cumulative revision rate for total hip arthroplasties was 1.29%, 2.99% and 4.57% at 
1-, 5- and 9-years follow-up, respectively, whereas the cumulative revision rate for partial 
hip arthroplasties was 1.23%, 2.11% and 2.38%, respectively. For total hip arthroplasties, 
an increased risk of revision was observed for patients under 65 years, patients aged 
65-75 years, and patients between 75-85 years compared to those aged 85 years or 
over (HR=2.87 (CI 95%: 1.47-5.61); HR=2.38 (CI 95%: 1.22-4.65); HR= 1.96 (CI 95%: 
1.00-3.84). A similar trend was observed for partial hip arthroplasties for patients aged 
65-75 years and 75-85 years (HR=2.81 (CI 95%: 1.78-4.45; HR=1.63 (CI 95%: 1.21-
2.20)). The Cox model considering the different friction devices and adjusted by age, 
sex, and comorbidities revealed an increased revision rate for metal-metal prosthesis in 
comparison to metal-polyethylene prosthesis (HR=1.43 CI 95%: 1.06-1.93).
Conclusions
The results presented in this report provide an overview of the quality of RACat’s data, the 
characteristics of arthroplasties carried out in Catalonia over the last 10 years, and the clinical 
effectiveness of primary knee and hip arthroplasties up to 9 years of follow-up. Although the 
volume and quality of data recorded in the RACat presented a positive trend over time, there is 
significant  variability per centre, which indicates room for improvement in the process of data 
acquisition and the need for defining strategies aimed  at ensuring  better quality reporting. 
In terms of clinical effectiveness, the results presented are consistent with the international 
literature. In our context, the RACat is being consolidated as a useful tool to analyse variations in 
patient characteristics and prosthesis utilization among hospitals or health regions in Catalonia, 
and may become a powerful system for post-market surveillance of implants. Improvements in 
data quality, the incorporation of new variables,the continuing increase of the follow-up period, 
along with consistently working closely with clinicians and key stakeholders, will enable to 
perform more robust and meaningful analysis that hopefully can foster improvements for the 
healthcare system.
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Presentation
The Catalan Arthroplasty Register (RACat, for its acronym in Catalan) was launched in 2005 in 
response to a common interest of the Catalan Health Service (CHS), the Catalan Society of 
Orthopaedic Surgery and Traumatology (SCCOT, for its acronym in Catalan), and the Agency 
for Health Quality and Assessment of Catalonia (AQuAS, for its acronym in Catalan). The RACat 
is a population-based register designed to assess the clinical effectiveness of hip and knee 
arthroplasties in Catalonia. Using the CHS Information System, publicly funded hospitals sent 
information to the RACat on knee and hip arthroplasties, including patient identification, hospi-
tal, joint (hip/knee), type (primary/revision), side of operation, date of surgery, and implants. The 
information is complemented by linking this data with other databases with the aim to complete 
the patient’s information, clinical procedures, and patient follow-up. The RACat was made pos-
sible thanks to the cooperation of professionals and participant centres, along with the collabo-
ration of manufacturers, which help with complementing implant information.
The 2005-2014 Hip and Knee Report is based on the analysis of 118,606 primary and revision 
knee and hip arthroplasties recorded by the Catalan Arthroplasty Register (RACat) with a pro-
cedure date up to and including 31 December 2014. It provides an update of the results pre-
sented before incorporating certain new aspects in comparison with previous reports. Firstly, the 
results for knee arthroplasties  are presented separately for total and partial arthroplasties. This 
differentiation provides a more accurate characterization of the implant outcomes and patient 
characteristics. As had been the case in previous reports, the results for hip arthroplasties are 
also presented by total and partial arthroplasties. Secondly, giving the increase of the follow-up 
period, we are able to show survival outcomes up to 9 years of follow-up. Nevertheless, the 
number of cases with long term follow up is relatively small for some subgroups, so these fig-
ures must be interpreted with caution when reading the current report. Lastly, we have incorpo-
rated information on head size for total conventional hip arthroplasties. This data provides a 
more complete overview for the characterization of hip implants and represents an opportunity 
to generate further analyses.
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1. Introduction
As has been the case  in most European countries, increases in degenerative illnesses due to 
the population ageing and changes in indication criteria, has led to a significant rise in the num-
ber of hip and knee arthroplasties in Catalonia in recent years1-4. Although these surgeries are 
among the most cost-effective medical procedures, significant variability in the clinical practice, 
along with waiting list problems and a high impact on healthcare budget have been highlighted5. 
After 10 years of operation, the RACat has been consolidated as a useful tool for information, 
evaluation, and guidance in clinical practice in Catalonia, and has also provided relevant data 
for professionals, public health bodies and manufacturers. In the context of Spain, , the RACat 
is a pioneering initiative that will be very valuable if a nationwide registry is eventually launched. 
On an international level, the RACat adds to more than 50 arthroplasy registers that are cur-
rently underway around the world, and collaborates with several networks on a European and 
global level. 
This report aims to provide updated information on knee and hip arthroplasties carried out in 
publicly funded Catalan hospitals between 2005 and 2014. In the following pages, you will find 
data on quality and completeness of the information, patient’s and implant characteristics, and 
prosthesis survival in the short, medium, and long-term. 
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2. Objectives
The objective of this report is to present the results of the information sent to the RACat during 
the period 2005-2014 regarding the characteristics of patients, arthroplasty interventions and 
implanted prostheses, along with the implant survival, and factors related with a better/worse 
prognosis of the primary hip and knee arthroplasties. 
The specific objectives are:
1.  To describe data sent to the RACat in terms of completeness and quality of the information, 
as well as the temporary evolution of the arthroplasties and the variability per centre. 
2.  To describe the characteristics of patients undergoing a knee or hip arthroplasty, the fixation 
techniques, models, characteristics of the implanted prostheses and trends over time. 
3.  To analyse the survival of knee and hip prosthesis in the short(at 1 year), medium (at 5 
years), and long-term (at 9 years).
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3. Methodology
3.1. Study population
The study population comprises all insured citizens by Catalan Health Service (CHS) who 
underwent hip or knee arthroplasty between January 2005 and December 2014 in a healthcare 
centre run by the Integrated Healthcare System of Public Healthcare Network of Catalonia (SIS-
CAT, for its acronym in Catalan). During this period 53 of 61 centres participated in a voluntary 
basis, sending data to the RACat. They represented over 85% of the activity that took place in 
the public sector in Catalonia. So far, RACat does not routinely gather data from private centres, 
but some centres have begun to adapt their information systems to RACat requirements.
The information provided in this report concerns the characteristics of primary arthroplasties 
given that they represent the majority of interventions, versus revisions. 
3.2. Data collection and sources of information
The RACat database is integrated in the Health Registers platform (RSA) of the CHS that 
includes a Web Service interface with other office applications, and is accessed through the 
Applications Portal of Health Department via on-line or Web Services. By using this platform, 
we ensure the secure transmission of data. 
Hospitals sent patient data to the RACat on implants, interventions and surgical techniques. The 
quality of the information sent to the RACat is reviewed periodically. The results of the review 
process are sent to the members of the Technical Group of each centre to correct errors; the 
validated information is sent back to the RACat. 
Data provided by centres are: a) patient’s Personal Identification Code (PIC); b) date of admis-
sion; c) date of intervention; d) date of discharge; e) joint (knee or hip) f) whether it is a primary 
or a revision arthroplasty; g) operated side (right or left); h) name of the manufacturer; i) refer-
ence number and batch number of every prosthesis component informed.
Based on the patient identifier data, the register data are linked with other data sources (Table 1). 
Central Insurance Register (RCA, for its acronym in Catalan). This is the register for per-
sons covered by CHS, and provides information on the patient’s date of birth, gender, place of 
residence, and status (death, alive or living outside Catalonia). Using the IIN sent by each cen-
tre, the information from the RCA is gathered with data sent by hospitals. 
Minimum basic data set for hospital discharge (MBDSHD). This dataset provides informa-
tion on the reason for intervention, the procedures performed and comorbidities. This dataset is 
provided by the CHS Activity Register Division. 
Catalogue of prostheses. This is produced by the RACat and is based on information provided 
by manufacturers and distributors of prostheses. This catalogue made possible to complete the 
information sent by hospitals about implants (name of the manufacturer, reference number, 
batch number of all components implanted and the cement used), and to identify the type of 
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component, the fixation technique, the friction device (in total hip arthroplasties), whether fixed 
or mobile-bearing is used (in total knee arthroplasties), the prosthesis models implanted and to 
group the type of arthroplasty following the RACat’s classification system (Table 2).
We are currently updating several variables included in the Catalogue related to prosthesis 
design, material, fixation, and component size. This information would allow us to carry out 
more detailed analysis and would enrich the current results. So far, the catalogue of prostheses 
offers information on more than 28,000 reference numbers pertaining to the primary compo-
nents of hip prostheses (stem, acetabulum, insert and head) and knee (femoral, tibial, tibial 
insert, patella) of 67 manufacturers. 
Table 1. Variables collected from RACat’s source information
Variables sent by hospital Variables RCA Variables MBDSHD Catalogue of prostheses
•  Personal Identification 
Code (PIC)
•  Centre 
•  Clinical history number 
(CHN) 
•  Date of admission and 
discharge*
•  Date of intervention 
•  Type of arthroplasty 
(primary, revision) 
•  Join (knee, hip) 
•  Operated side (right, left) 
•  Prosthesis information 
(manufacturer, reference 
and batch number) 
•  IIN 
•  Sex 
•  Date of birth 
•  Status patient 
•  Basic health unit 
•  Health sector 
•  Health care region 
•  IIN 
•  Centre 
•  CHN 
•  Date of admission / 
discharge 
•  Health care region 
•  Sex 
•  Principal / secondary 
diagnosis (reason for 
surgery; comorbidities) 
•  Principal procedure 
•  Hospital stay 
•  Discharge from social and 
health services centres 
•  Level of hospital complexity
•  Manufacturer
•  Reference number
•  Trademark / brand name
•  Joint type
•  Type of implant
•  Design
•  Modularity
•  Mobility
•  Fixation
•  Fixation surface
•  Bearing surface (MoP, 
PoC, CoC, MoM)
•  Size
•  Side
Data of discharge is available from November 2013 onwards
RCA: Central Insurance Register; MBDSHD: Minimum basic data set for hospital discharge; MoP: Metal on Polyeth-
ylene; PoC: Polyethylene on Ceramic; CoC, Ceramic on Ceramic; MoM: Metal on Metal.
RACat’s surgical form. A surgical form was agreed by the Catalan Society of Orthopaedic 
Surgery and Traumatology (SCCOT, for its acronym in Catalan). This form includes information 
on the patient, surgery, intervention, implants and intraoperative complications6. Since the end 
of 2013, the variables of the surgical form have been integrated into  RACat’s information Sys-
tem. Some hospitals have started to report the variables of this form, but we are still in the 
implementation phase.
3.3. Data protection and confidentiality 
The RACat is part of the CHS Information System, guaranteeing compliance with the applicable 
regulations on data protection (RD994/1999, of June 11; organic Law 15/1999, of 13 December; 
RP 428/1993, of 26 March) and ensuring that the information is transmitted via secure commu-
nication. In accordance with legal regulations in force, data is anonymised to carry out specific 
analysis.
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3.4. Quality control and data validation
The quality of the information sent to the RACat is reviewed periodically. As part of the review 
process, we check the information related to prosthesis, patients, and arthroplasties. The data 
review circuit is detailed in Figure 1. 
Figure 1. Data review circuit
Prosthesis information
- Manufacturer
- Reference number
- Batch number
Manufacturers
Centre-by-centre
review
General information
- Clinical history number 
not available
- Joint discrepancies
- Surgery date 
discrepancies
- Laterality
- Duplicates
Data validation
- By merging data with 
the Minimum Basic 
Dataset for Hospital 
Discharge (gold 
standard)
Technical Group of 
each Centre
If the
company 
does not
recognise the
reference
number
Key
Errors 
Report
In case of 
hugh
discrepancies
on the number 
of in episodes
comparison 
with previos
years
3.5. Primary arthroplasty classification system 
In order to group the different types of arthroplasties implanted, centres must send the neces-
sary information regarding prosthesis components. RACat uses the classification system 
showed in Table 2, which was adapted from the Australian Orthopaedic Association National 
Joint Replacement7.
Primary knee arthroplasties 
The knee joint is divided into three major compartments: patellofemoral, medial and lateral 
femo rotibial joint. The type of arthroplasty is defined depending on the number of compartments 
replaced (Table 2): a) Partial knee arthroplasties: when one or two compartments are replaced 
(patellofemoral and/or femorotibial). b) total knee arthroplasty (TKR), when two or three com-
partments are replaced. Within partial knee arthroplasties we differentiate between: unicom-
partmental (UKA), when a single compartment is replaced (medial or lateral tibiofemoral); 
bicompartmental, when the medial or lateral and patellofemoral compartments are replaced; 
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and patellofemoral, if only this compartment is replaced. Furthermore, total arthroplasties are 
classified into different groups, depending on the joint range of motion and whether cruciate and 
collateral ligaments are preserved or not: cruciate retaining (CR), cruciate substituting or poste-
rior stabilized (PS), constrained, hinged and tumoral (in these latter two categories collateral 
ligaments are not preserved).
Primary hip arthroplasties 
Two large groups of arthroplasties have been defined: partial and total arthroplasty, when a part 
or all of the joint is replaced, respectively: a) partial hip arthroplasty (PHA), if femoral joint is 
replaced, and b) total hip arthroplasty (THA) when acetabulofemoral joint is replaced (Table 2). 
In addition, partial arthroplasties are grouped as: unipolar monoblock when only a stem is 
implanted, unipolar modular, when a stem and a cephalic component is implanted, and bipolar, 
where a stem and a bipolar head component are implanted. In the case of total arthroplasties, 
they are grouped as: conventional, when a stem, head and acetabulum are implanted; resurfac-
ing, when a large head and cup are implanted and the femoral head is not removed; Dual mobil-
ity acetabular component (also known as unconstrained tripolar implant) when a dual-articulation 
acetabular cup is used; and with short stem, when a short stem, head and acetabulum are 
implanted.
Table 2. Classification system for primary hip and knee arthroplasties
Type of arthroplasty 
Knee Hip 
Partial knee arthroplasty (PKA)
Patellofemoral 
Unicompartmental femorotibial (UKA)
Bicompartmental
Total knee arthroplasty (TKA) 
Cruciate retaining (CR) 
Posterior stabilised (PS) 
Constrained 
Hinged 
Tumoral 
Partial hip arthroplasty (PHA) 
Unipolar monoblock 
Unipolar modular 
Bipolar 
Total hip arthroplasty (THA) 
Resurfacing
With short stem
Conventional
Dual Mobility o tripolar
3.6. Statistical analysis
The analyses were structured in three areas, in line with the proposed objectives: quality and 
completeness of the data, descriptive analyses and survival analyses. 
Completeness and quality of the information 
To analyse the quality of the data and the completeness of the information, the information from 
the RACat and the Minimum Basic Data Set at Hospital Discharge (MBDSHD) was considered. 
To this end, the analysis accounted for all patients covered by CHS who received a knee or hip 
arthroplasty in one of the centres collaborating with the RACat (n=118,606) from January 2005 
to December 2014, including 66,881 knee arthroplasties and 51,725 hip arthroplasties. We only 
considered the public activity carried out in Catalonia over the study period.
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MBDSHD is a comprehensive clinical and administrative database on all health and morbidity 
activity conducted in public and private hospitals in Catalonia. Thus, the activity of the 53 hospitals 
participating in the RACat is recorded herein. We used this database as a gold standard to calcu-
late the completeness of the RACat. The information of both registers was linked together using 
the patient’s IIN, centre, admission date, joint, and type of arthroplasty (primary or revision). 
A descriptive analysis of the number of arthroplasties (volume) included in the RACat per year 
and period (2005-2006; 2007-2008; 2009-2010; 2011-2012; 2013-2014) was carried out. The 
completeness of the RACat’s data, per centre and year, was calculated. Completeness was 
considered to be the ratio between the arthroplasties volume sent to the RACat and the arthro-
plasties volume sent to the MBDSHD by participating hospitals during the 2005-2014 period. A 
funnel plot between the completness of each centre and the case volume sent to the RACat, in 
an anonymized way, was plotted. To do this, the overall completeness of all participating centres 
of the RACat with a 95 % confidence interval was used as a reference. 
Two indicators were defined to assess the quality of the data: the percentage of primary knee 
and hip arthroplasties that were identified following the classification system used in the RACat 
(Table 2) and the percentage of cases sent to the RACat with the operated side informed (right 
or left). A funnel plot for each indicator with the result of every centre and the case volume sent 
to the RACat, was also anonymous. It was used as a reference for the overall result with a 95 
% confidence interval. 
The funnel plot is recommended as a visual aid to benchmark centres. In this type of graph, an 
estimate of an indicator versus an interpretable precision measure is drawn. The limits of control 
draw the shape of a funnel over the objective result control. In the case of centres that are above 
or below the limits of control, the value of the indicator will be interpreted as being above or 
below the set or target outcome.
Descriptive analyses of patients and arthroplasties 
To perform the descriptive analyses, all cases in which there was correspondence between the 
data from the RACat and the MBDSHD were selected, thus ruling out 6.8% of cases. This 
meant a total selection of 110,618 arthroplasties (61,565 knee arthroplasties and 47,428 hip 
arthroplasties).
For each type of joint (hip and knee), a descriptive analysis was carried out (first by overall data 
and then by health care regions) of the patient characteristics (volume, sex, age and type of 
arthroplasty). At the same time, and only for those patients included in the RACat and linked 
with the MBDSHD, other questions related to morbidity and the care delivery process were 
described (reason for surgery, comorbidities, hospital stay and percentage of referrals to a con-
valescence centre at hospital discharge).
The global burden of revision, the percentage of revisions sent to the RACat compared to 
total number of interventions sent (primary and revisions), was calculated. This index provides 
the percentage of revisions undertaken in a given period in relation to the total number of inter-
ventions. In contrast with the cumulative revision rate, revision procedures described in the 
burden revision during 2005-2014, do not necessarily correspond to patients who underwent a 
primary arthroplasty in the same period (it is a cross-sectional cut without a follow-up). 
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Fixation technique (cemented, uncemented and hybrids) and the type of arthroplasty used 
were described per age group and period; and, in the case of conventional hip arthroplasties, 
the friction device (metal-metal, metal-polyethylene, ceramic-polyethylene and ceramic-ce-
ramic) was also described overall and per age group. The five most common implant models 
have been described by type of arthroplasty and fixation technique. 
Information on head size among conventional hip arthroplasties was also analysed. This varia-
ble was groped in 3 categories: small heads, if the head diameter was <32mm; medium heads, 
when the head diameter ranged between 32 and 36 mm; and large heads, when the head diam-
eter was >36mm. 
Implant survival analysis
As for the survival analyses, these excluded not only cases where there was no data link 
between the RACat and the MBDSHD, but also cases where the side (right or left) could not be 
determined, and cases in which information was received about the revision surgery but not 
about the primary surgery. As a result, these analyses covered a total of 46,406 knee arthroplas-
ties and 31,603 hip arthroplasties. 
A survival analysis was conducted considering the time elapsed from the primary arthroplasty 
until the revision of the prosthesis, irrespective of the reason for revision. A revision arthroplasty 
was defined as any procedure involving removal, exchange or addition of any implant part.
Cases were censured at the date of death, at the date of discharge from Catalonia to other 
Spanish autonomous communities or foreign countries (patients no longer affiliated to the CHS) 
or at 31st December 2014 if no event occurred before the end of the study, whatever occurred 
first. 
The cumulative revision rate for knee arthroplasties was estimated for partial and total proce-
dures, by the type of fixation and according to the type of arthroplasty. For hip arthroplasties, 
differentiated analyses were carried out for partial and total procedures. For the latter ones, the 
cumulative rate by friction device was also considered. When calculating the cumulative revi-
sion rates, the actuarial adjustment by the number of patients at risk of replacement was con-
sidered for each time interval. 
To find out the revision rates at short-term or to year basis, the following intervals of time were 
used: 0 to 30 days, 30 to 90 days, 90 days to 1 year, 1 to 3 years, 3 to 5 years, 5 to 7 years and 
7 to 9 years. 
On the other hand, Cox proportional-hazard regression models were fitted to explore the effects 
of different factors in the revision arthroplasties adjusted by different covariates8. The hazard 
ratio (HR) of revision was estimated depending on the type of fixation, adjusted by patient age 
and sex. These models allow considering the elapsed time until the event or the censorship, with 
proportional risk assumption. The reading of a HR corresponds to that of a relative risk. There-
fore, a HR>1, where 1 is not included in the 95% confidence intervals (CI), measures how high 
the risk for replacement in patients with the factor is, in relation to the ones that do not have it. 
In order to adjust the analyses by risk of patient death, we also fitted Cox proportional-hazard 
models for competing risks of Fine and Grey9. 
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4. Knee Arthroplasties 
results
4.1. Scope and quality of data
In the period described, data from 60,192 patients with primary arthroplasty and from 6,689 
patients with revision knee arthroplasty were received. As shown in Figure 2 and Table 3 the 
volume of data increased over the first three periods in most health regions, suffering a slight 
decrease from 2012 onwards.
Table 4 shows the volume of primary and revision arthroplasties sent during the study period, 
per centre. The overall burden of revisions, understood as the percentage of revision arthroplas-
ties compared to the total number of events sent, was 10.0%. Remarkable disparities were 
found between centres with a minimum burden of 0% and a maximum of 24.8%.
Figure 3 shows the completeness by type of knee arthroplasty (primary or revision) over the 
years. It can be observed that the highest completeness both for primaries and revisions was 
reached in 2011. A gradual decrease was observed from 2012 onwards, coinciding with techni-
cal changes in data notification. Figure 4 shows the variability in data completeness of each 
centre (blue points) compared with overall completeness (green line) and a confidence interval 
based on overall completeness. The centres that are below the range of the confidence interval 
exhibit lower completeness compared to the overall figure, and the ones that are above exhibit 
higher completeness than the overall. Only 9 out of the 53 centres fell below the confidence 
interval based on the overall reference value. 
As a quality indicator of data, we calculated the percentage of arthroplasties that had been clas-
sified following the RACat’s classification. Considering the whole period, the percentage of clas-
sified primary arthroplasties was 82.2% (Table 5). Figure 5  is a funnel plot showing the 
percentage of classified primary arthroplasties per centre in relation to the volume of data sent 
in the period 2013-2014. As can be seen, almost all the healthcare centres present percentages 
around 80%, which indicates good data quality of the information sent.  
The percentage of arthroplasties with reported laterality increased over the study period reach-
ing 99.9% in 2013-2014  (Table 6). Considering data from the latter 2 years we plotted percent-
age of laterality reported per centre (Figure 6). Here we can see that  all centres reported 
correctly this variable correctly in 2013-2014.
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Figure 2. Volume of knee arthroplasties sent to the RACat per year, and by type of arthroplasty. Source 
RACat
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
Primary 1.458 3.716 3.868 4.157 5.086 5.755 5.472 5.938 5.517 5.521 
Revision  151 411 414 476 598 748 716 609 522 592 
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Table 3. Number of knee arthroplasties by health region period and by type of arthroplasty. Source RACat.
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Lleida 216 15 515 31 604 48 640 27 798 8 2,773 129
Camp de Tarragona 129 3 817 30 1,157 46 1,014 31 1,017 65 4,134 175
Terres de l’Ebre 0 0 0 0 637 59 400 36 305 48 1,342 143
Girona 1,190 83 1,511 118 1,829 169 1,496 159 1,687 102 7,713 631
Catalunya central 615 43 1,137 93 1,218 176 1,164 200 1,282 153 5,416 665
Alt Pirineu i Aragó 97 3 116 0 135 3 134 6 124 0 606 12
Barcelona 5,576 476 7,491 773 9,239 1,189 8,317 1,079 7,585 1,417 38,208 4,934
Total 7,823 623 11,587 1,045 14,819 1,690 13,165 1,538 12,798 1,793 60,192 6,689
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Table 4. Number of knee arthroplasties by health care region, centre, period and by type of arthroplasty. 
Source RACat.
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014 Total
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Lleida
Hospital Universitari Arnau  
de Vilanova
0 0 0 2 108 12 161 4 255 2 524 3.7
Hospital de Santa Maria 164 9 307 20 324 21 284 18 330 4 1,409 4.9
Clínica de Ponent 52 6 208 9 172 15 195 5 213 2 840 4.2
Camp de Tarragona
Hospital Universitari de 
Tarragona Joan XXIII
1 0 129 17 254 23 277 12 323 24 984 7.2
Hospital Universitari Sant 
Joan de Reus
2 0 92 0 313 0 241 1 127 0 775 0.1
Hospital de Sant Pau i 
Santa Tecla
36 0 203 6 220 13 211 10 237 12 907 4.3
Pius Hospital de Valls 87 3 156 3 120 4 112 2 132 10 607 3.5
Hospital del Vendrell 3 0 237 4 250 6 173 6 198 19 861 3.9
Terres de l´Ebre
Hospital Tortosa Verge de  
la Cinta
0 0 0 0 309 59 200 36 227 48 736 16.3
Hospital Comarcal  
Móra d’Ebre
0 0 0 0 328 0 200 0 78 0 606 0.0
Girona
Hospital Universitari de 
Girona Josep Trueta
0 0 243 34 173 53 243 47 389 12 1,048 12.2
Clínica Girona SA 0 0 0 0 200 11 167 4 122 0 489 3.0
Clínica Salus Infirmorum 0 0 0 0 0 0 0 0 39 3 39 7.1
Hospital Comarcal de 
Blanes
287 35 358 29 384 26 266 20 272 14 1,567 7.3
Hospital de Campdevanol 46 0 51 0 53 0 44 0 63 0 257 0.0
Hospital de Figueres 178 13 343 26 356 28 257 37 91 8 1,225 8.4
Hospital de Palamós 272 20 282 12 277 18 191 19 234 38 1,256 7.9
Hospital de Sant Jaume 
d’Olot
223 13 44 7 149 17 86 18 145 12 647 9.4
Hospital Provincial Santa 
Caterina
184 2 190 10 237 16 242 14 332 15 1,185 4.6
Catalunya Central
Centre Hospitalari- 
ALTHAIA
372 37 778 62 674 127 610 134 598 103 3,032 13.3
Hospital General de Vic 154 1 123 4 224 7 288 33 372 32 1,161 6.2
Hospital de Sant  
Bernabé
0 0 51 4 122 8 103 8 150 5 426 5.5
Fundació Sanitaria 
d’Igualada FP
89 5 185 23 198 34 163 25 162 13 797 11.2
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Alt Pirineu i Aran
Fundació Sant Hospital de 
la Seu d’Urgell
50 1 46 0 51 3 38 4 46 0 231 3.4
Hospital Comarcal del  
Pallars
22 0 29 0 64 0 64 0 65 0 264 0.0
Hospital de Puigcerdà 25 2 21 0 20 0 32 2 13 0 111 3.5
Barcelona
Hospital de Viladecans 0 0 0 0 108 13 190 14 177 1 475 5.6
Hospital Universitari de 
Bellvitge
292 0 276 0 482 11 351 16 200 4 1,601 1.9
H.Universitari Germans 
Trias i Pujol
0 0 35 3 376 36 346 18 463 3 1,220 4.7
Hospital Clinic i Provincial 
de Barcelona
1,612 174 1,062 275 1,242 319 834 294 824 272 5,574 19.3
Hospital de L’Hospitalet - 
CSI
599 37 458 29 537 55 411 52 7 489 2,012 24.8
Hospital Dos de Maig de 
Barcelona - CSI
114 6 114 9 231 11 244 9 137 118 840 15.4
Hospital Mútua de  
Terrassa
0 0 389 44 581 52 493 68 158 23 1,621 10.3
Hospital de l’Esperit  
Sant
185 11 306 27 391 50 284 22 375 9 1,541 7.2
Corporació Sanitária Parc 
Taulí
231 32 639 84 630 82 542 63 326 96 2,368 13.1
Hospital de Sant Boi- Parc 
Sanitari St Joan de Deu
225 14 307 14 237 32 219 25 318 24 1,306 7.7
Hospital de Sant Celoni - 
Fundació privada
99 11 174 13 130 25 154 12 134 6 691 8.8
Hospital de Terrassa 0 0 257 28 287 27 239 17 371 16 1,154 7.1
Parc de Salut del Mar 139 27 414 26 506 88 750 125 0 0 1,395 14.7
Hospital General de 
Granollers
257 35 339 18 83 11 327 34 391 49 1,472 9.5
Hospital Municipal de 
Badalona
330 20 268 83 289 20 191 21 252 18 1,401 6.5
Hospital Residència Sant 
Camil
364 41 289 18 213 68 126 24 192 25 1,163 17.2
Hospital Sant Joan de Déu 
de Martorell
108 7 0 0 270 29 149 49 80 28 896 12.8
Hospital de Sant Joan de 
D`Esplugues Llob
0 0 0 0 1 0 0 0 1 0 2 0.0
Hospital Sant Rafael 0 0 0 0 378 54 302 57 368 49 1,048 13.3
F.G.S. Hospital de la Santa 
Creu i Sant Pau
0 0 0 0 226 29 394 50 427 54 1,047 11.3
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Barcelona (cont.)
H. de Plató 0 0 133 7 150 10 58 2 77 3 418 5.0
Hospital Universitari Sagrat 
Cor
315 38 495 43 543 49 618 47 755 55 2,726 7.8
Fundació Privada Hospital 
de Mollet
135 7 146 11 152 4 220 6 289 1 942 3.0
Hospital Comarcal de l’Alt 
Penedes
0 0 166 13 165 29 136 12 186 22 653 10.4
Hospital de Mataro 116 16 412 28 448 30 275 17 280 26 1,531 7.1
H. Universitari Vall 
d’Hebron
455 0 812 0 583 55 464 25 797 26 3,111 3.3
Total 7,823 623 11,587 1,045 14,819 1,690 13,165 1,538 12,798 1,793 60,192 10.0
Figure 3. Completeness of data sent to the RACat per year, and by type of arthroplasty. Source RACat-MBD-
SHD
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
Primary 67,7 75,7 75,2 75,4 78,2 91,3 94,3 89,5 79,8 69,6 
Revision 50,6 57,2 58,1 50,0 62,0 72,0 70,5 65,3 54,8 35,3 
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Figure 4. Percentage of completeness of primary knee arthroplasties per centre during the period 2013-
2014. Source: RACat 
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Table 5. Percentages of classified primary knee arthroplasties in relation to the volume sent to the RACat. 
Source: RACat.
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014 Total
n % n % n % n % n % n %
Classified 4,637 59.3 9,409 81.2 12,925 87.2 12,003 91.2 10,486 81.9 49,460 82.2
Not Classified 3,186 40.7 2,178 18.8 1,894 12.8 1,162 8.8 2,312 18.1 10,732 17.8
Total 7,823 100.0 11,587 100.0 14,819 100.0 13,165 100.0 12,798 100.0 60,192 100.0
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Figure 5. Percentages of classified primary knee arthroplasties per centre in relation to the volume of data 
sent in the period 2013-2014. Source: RACat.
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Table 6. Number of knee arthroplasties with the operated side (left or right) reported by period. Source 
RACat.
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014 Total
n % n % n % n % n % n %
Reported  6,030 71.4 11,892 94.1 16,144 97.8 14,581 99.2 14,574 99.9 63,221 94.5
Not reported 2,416 28.6 740 5.9 365 2.2 122 0.8 17 0.1 3,660 5.5
Total 8,446 100.0 12,632 100.0 16,509 100.0 14,703 100.0 14,591 100.0 66,881 100.0
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Figure 6. Percentage of primary arthroplasties and knee replacements with reported laterality per centre in 
relation to volume of data sent in the latter period. Source RACat.
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4.2. Demographic and patient treatment process profile
From this section on, the results are presented split by total and partial knee arthroplasties. 
The average age of patients undergoing a primary total knee arthroplasty was 72.2 years (stand-
ard deviation; SD: 7.6) and for those who underwent a partial knee arthroplasty was 65.5 years 
(SD: 9.7), being the percentage of women 71.4% and 67.0%, respectively (Table 7, Table 8).  
In the time period spanning between 2005 and 2014, the age group distribution among patients 
with a total knee arthroplasty remained relatively stable (Figure 7). However, for those patients 
who experienced a partial knee arthroplasty the percentage of patients aged between 75 to 84 
years increased over time.
Table 9 and Table 10 shows the demographic characteristics and treatment profile of patients 
who underwent total and partial knee arthroplasty, respectively. Patients undergoing a primary 
total knee arthroplasties were older that those undergoing a partial procedure, the mean age for 
the period 2013-2014 being 72.3 years and 66.8 years, respectively. The data shows  that the 
main reason for intervention of arthroplasties carried out during the latter study period was oste-
oarthritis in 98.7% of primary total knee arthroplasties and 96.9% for partial knee arthroplasties. 
For the latter group, a gradual increase of this cause of intervention over time was observed. 
Mechanical complications were the main cause for revision both for total and partial knee arthro-
plasties. As expected by differences in patient’s age distribution, the percentage of patients with 
1 or more comorbidities was higher for patients undergoing total knee arthroplasties in compar-
ison to those undergoing a partial knee arthroplasty. 
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Table 7. Age and sex of patients undergoing a primary total knee arthroplasty by health care regions and period. Source RACat.
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014 Total
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Lleida 197 72.9 (6.2) 68.0 460 73.9 (6.5) 67.6 556 73.0 (6.8) 66.7 562 73.3 (7.1) 65.8 511 72.9 (7.5) 68.1 2,286 73.3 (7.0) 67.1
Camp de Tarragona 126 72.6 (6.0) 71.4 643 72.4 (6.9) 69.1 827 72.2 (6.8) 71.5 756 71.8 (7.2) 71.0 875 72.1 (7.2) 67.5 3,227 72.2 (7.0) 69.8
Terres de l’Ebre 0 0 0.0 0 0 0.0 301 71.4 (7.2) 57.8 180 71.3 (7.7) 61.1 161 71.6 (7.9) 57.8 642 72.1 (7.6) 58.7
Girona 926 72.2 (7.1) 69.2 1,081 71.8 (7.2) 68.2 1,314 72.1 (7.6) 67.0 1,183 71.9 (8.2) 67.3 1,445 72.0 (8.0) 65.5 5,949 72.0 (7.7) 67.2
Catalunya central 441 72.1 (7.4) 72.8 1,029 71.6 (7.8) 70.1 1,142 72.0 (7.5) 68.9 1,107 72.1 (7.6) 70.0 1,230 72.5 (7.5) 70.8 4,949 72.1 (7.6) 70.2
Alt pirineu i Aran 83 72.9 (8.0) 62.7 114 73.4 (7.5) 68.4 129 75.0 (7.7) 64.3 128 73.6 (6.3) 61.7 117 73.4 (7.0) 65.0 571 73.7 (7.3) 64.5
Barcelona 2,759 72.1 (7.3) 74.2 5,855 72.2 (7.5) 74.3 8,266 72.2 (7.7) 73.5 7,738 72.3 (7.7) 72.7 5,710 72.4 (7.8) 72.0 30,328 73.2 (7.7) 73.2
Total 4,532 72.2 (7.2) 72.5 9,182 72.2 (7.4) 72.3 12,535 72.2 (7.6) 71.5 11,654 72.3 (7.7) 71.1 10,049 72.3 (7.7) 70.0 47,952 72.2 (7.6) 71.4
Table 8. Age and sex of patients undergoing a primary partial knee arthroplasty by health care region and period. Source RACat.
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014 Total
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Lleida 0 0 0 0 0 0 0 0 0 0 0 0 1 53.4 0 1 53.4 0
Camp de Tarragona 1 56.5 100.0 11 62.5 (7.4) 81.8 8 66.4 (7.7) 62.5 8 64.9 (8.0) 62.5 6 60.4 (2.1) 33.3 34 63.4 (7.1) 64.7
Terres de l’Ebre 0 0 0.0 0 0 0.0 5 62.1 (4.6) 60.0 1 61.2 100.0 0 0 0.0 6 61.9 (4.1) 66.7
Girona 6 62.1 (8.1) 83.3 15 65.1 (8.3) 66.7 17 65.5 (7.9) 64.7 8 58.5 (8.7) 75.0 6 59.1 (4.1) 66.7 52 63.7 (8.4) 69.2
Catalunya central 5 53.8 (8.6) 60.0 24 59.2 (9.0) 79.2 37 57.6 (9.4) 73.0 31 58.6 (8.8) 58.1 25 59.5 (10.5) 64.0 122 58.3 (9.3) 68.0
Alt pirineu i Aran 6 72.4 (8.1) 50.0 2 50.4 (1.1) 50.0 6 63.9 (10.4) 66.7 6 64.3 (11.0) 83.3 1 65.3 100.0 21 64.8 (10.3) 66.7
Barcelona 86 65.6 (8.3) 67.4 171 65.2 (9.6) 64.3 309 65.8 (9.4) 68.0 287 66.5 (10.1) 73.2 386 67.6 (9.2) 62.4 1,239 66.4 (9.5) 66.9
Total 104 65.2 (8.8) 67.3 223 64.3 (9.5) 66.8 382 65.0 (9.6) 68.1 341 65.5 (10.0) 71.9 425 66.8 (9.5) 62.1 1,475 65.6 (9.7) 67.0
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Figure 7. Age of patients undergoing a primary knee arthroplasty by period. A) Total arthroplasties.   
B) Partial arthroplasties. Source RACat. 
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Table 9. Demographic and patient treatment profile of patients with primary and revision total knee arthro-
plasty by period. Source RACat-MBDSHD.
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014
P
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n
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n
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n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n n
Number 4217 183 8,856 452 12,107 796 11,432 686 9,769 484
% of Women
3,068 
(72.8)
120 
(65.6)
6,417 
(72.5)
322 
(71.2)
8,663 
(71.6)
601 
(75.5)
8,133 
(71.1)
506 
(73.8)
6,831 
(69.9)
371 
(76.7)
Mean age (SD)
72.1 
(7.1)
73.1 
(7.7)
72.2 
(7.4)
72.6 
(8.2)
72.2 
(7.6)
73.0 
(8.1)
72.2 
(7.7)
73.3 
(8.9)
72.3 
(7.7)
73.0 
(8.9)
Cause of intervention
Osteoarthritis
4,111 
(97.5)
8,681 
(98.0)
11,905 
(98.3)
11,264 
(98.5)
9,646 
(98.7)
Other diagnostics
106 
(2.5)
175 
(2.1)
202 
(1.6)
168 
(1.5)
123 
(1.3)
Cause of revision
Mechanical  
complications
119 
(65.0)
253 
(56.0)
518 
(65.1)
485 
(70.7)
357 
(73.8)
Infection
26 
(14.2)
34 
(7.5)
81 
(10.2)
53 
(7.7)
20 
(4.13)
Other diagnostics
38 
(20.8)
165 
(36.5)
197 
(24.8)
148 
(21.6)
107 
(22.1)
Comorbidity
1 or more
2,459 
(58.3)
99 
(54.1)
5,667 
(64.0)
281 
(62.1)
8,206 
(67.8)
547 
(68.7)
8,224 
(71.9)
496 
(72.3)
7,229 
(74.0)
372 
(76.8)
Healthcare discharge
229 
(5.43)
8 (4.4)
582 
(6.6)
39 
(8.6)
903 
(7.5)
59 
(7.4)
1185 
(10.4)
69 
(10.1)
870 
(8.9)
48 
(9.9)
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Table 10. Demographic and patient treatment profile of patients with primary and revision partial knee 
arthroplasty by period. Source RACat-MBDSHD
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014
P
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ev
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n
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ar
y
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ev
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n
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n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Number 94 0 219 0 371 3 336 2 424 0
% of Women
63 
(67.0)
0
145 
(66.2)
0
252 
(67.9)
1 (33.3)
243 
(72.3)
2 (100)
264 
(62.3)
0
Mean age (SD)
65.2 
(8.9)
0
64.4 
(9.5)
0
65.0 
(9.6)
68.4 
(2.0)
65.7 
(10.2)
65.7 
(0.6)
66.8 
(9.5)
0
Cause of intervention
Osteoarthritis
73 
(77.7)
185 
(84.5)
325 
(87.6)
308 
(91.7)
411 
(96.9)
Other bone and 
cartilage diseases
14 
(14.9)
18 
(8.2)
21 
(5.7)
18 
(5.4)
5 (1.2)
Other diagnostics
7 
(7.5)
16 
(7.3)
25 
(6.7)
10 
(3.0)
8 (1.9)
Cause of revision
Mechanical  
complications
0 0 2 (66.7) 1 (50.0) 0
Other diagnostics 0 0 1 (33.3) 1 (50.0) 0
Comorbidity
1 or more
34 
(36.2)
0
111 
(50.7)
0
216 
(58.2)
2 (66.7)
214 
(63.7)
1 (50.0)
261 
(61.6)
0
Healthcare discharge 0 0 0 0 1 (0.3) 0
11 
(3.3)
0 7 (1.7) 0
Revision information refers to the partial prosthesis used in a revision procedure. In general, partial arthroplasties are 
exchanged by a total knee prosthesis.
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4.3. Characteristics of primary arthroplasties
An overall of 49,427 knee arthroplasties could be classified for the whole study period. Total 
knee arthroplasties represented 97.0%, whereas partial knee arthroplasties represented 3.0%. 
Within total knee arthroplasties, the most common arthroplasties were those which preserve the 
posterior cruciate retaining (CR) and the posterior stabilized ones (PS), representing 46.0% and 
51.7%, respectively (Table 11). Among partial knee arthroplasties, unicompartmental arthro-
plasties were the most common group followed by patellofemoral arthroplasties, representing 
the 82.9% and 16.3% of partial procedures, respectively. 
The most frequent primary knee arthroplasties across age groups were also CR and PS (Figure 
8). Unicompatmental prosthesis was the most common type among partial procedures, espe-
cially among older patients. 
The most common fixation was cemented fixation both for total and partial knee arthroplasties 
(Table 12, Table 13 and Figure 9). Again, in total and partial knee arthroplasties the most com-
mon fixation technique in men and women (Table 14, Table 15) and across age groups (Table 
16 and Table 17) was cemented fixation.
In relation to the type of arthroplasty, the cemented fixation technique was the most used over-
all. CR and PS were cemented in 63.8% and 87.7% of cases, respectively (Table 18). For partial 
knee arthroplasties, cemented fixation was the most common fixation type both for unicompart-
mental and patellofemoral prosthesis (Table 19).
Figure 8. Percentage distribution of primary knee arthroplasties by age group. A) Total arthroplasties; B) 
Partial arthroplasties. Source RACat.
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Table 11. Number of primary knee arthroplasties per type of arthroplasty and period.
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014 Total
n % n % n % n % n % n %
Total knee arthroplasties
Posterior cruciate 
retaining (CR)
2,060 45.5 3,875 42.2 5,649 45.1 5,604 48.1 4,856 48.3 22,044 46,0
Posterior stabilized 
(PS)
2,403 53.0 5,061 55.1 6,579 52.5 5,842 50.1 4,892 48.7 24,777 51,7
Constrained 42 0.9 104 1.1 132 1.1 93 0.8 156 1.6 527 1,1
Tumoral 0 0.0 2 0.0 1 0.0 5 0.0 8 0.1 16 0,0
Hinge 3 0.1 24 0.3 44 0.4 25 0.2 40 0.4 136 0,3
Rotational 24 0.5 116 1.3 130 1.0 85 0.7 97 1.0 452 0,9
Partial knee arthroplasties
Patellofemoral 2 1.9 46 20.6 78 20.7 73 21.4 41 9.7 240 16,3
Unicompartmental 102 98.1 176 78.9 293 77.7 268 78.6 384 90.4 1223 82,9
Bicompartmental 0 0.0 1 0.5 6 1.6 0 0.0 0 0.0 7 0,5
Other types 1 100.0 4 100.0 13 100.0 8 100.0 12 100.0 33 100.0
Not specified 3,186 100.0 2,178 100.0 1,894 100.0 1,162 100.0 2,312 100.0 10,732 100.0
Total 7,823 100.0 11,587 100.0 14,819 100.0 13,165 100.0 12,798 100.0 60,192 100.0
Table 12. Number of primary total knee arthroplasties per fixation technique by time period. Source: RACat.
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014 Total
n % n % n % n % n % n %
Cemented 3,235 71.4 6,841 74.5 9,314 74.3 8,999 77.2 7,901 78.6 36,290 75.7
Cementless 36 0.8 66 0.7 230 1.8 85 0.7 23 0.2 440 0.9
Hybrid 1,111 24.5 1,667 18.2 1,967 15.7 1,378 11.8 960 9.6 7,083 14.8
Inverse hybrid 0 0.0 50 0.5 131 1.1 99 0.9 72 0.7 352 0.7
Not specified 150 3.3 558 6.1 893 7.1 1,093 9.4 1,093 10.9 3,787 7.9
Total 4,532 100.0 9,182 100.0 12,535 100.0 11,654 100.0 10,049 100.0 47,952 100.0
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Table 13. Number of primary partial knee arthroplasties per fixation technique by time period. Source: RACat.
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014 Total
n % n % n % n % n % n %
Cemented 99 95.2 173 77.6 299 78.3 264 77.5 372 87.5 1,202 81.5
Cementless 3 2.9 3 1.4 3 0.8 2 0.6 0 0.0 11 0.8
Not specified 2 1.9 47 21.1 80 20.9 75 22.0 53 12.5 257 17.4
Total 104 100.0 223 100.0 382 100.0 341 100.0 425 100.0 1,475 100.0
Figure 9. Percentage distribution of the fixation technique in primary knee arthroplasties by time period.  
 A) Total knee arthroplasties; B) Partial knee arthroplasties. Source: RACat
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Table 14. Number of primary total knee arthroplasties per fixation technique by sex. Source RACat.
Men Women Total
n % n % n %
Cemented 9,998 72.8 26,292 76.8 36,290 75.7
Cementless 152 1.1 288 0.8 440 0.9
Hybrid 2,018 14.7 5,065 14.8 7,083 14.8
Inverse hybrid 68 0.5 284 0.8 352 0.7
Not specified 1,497 10.9 2,290 6.7 3,787 7.9
Total 13,733 100.0 34,219 100.0 47,952 100.0
Table 15. Number of primary partial knee arthroplasties per fixation technique by sex. Source RACat
Men Women Total
n % n % n %
Cemented 412 84.6 795 80.5 1,207 81.8
Cementless 6 1.2 5 0.5 11 0.8
Not specified 69 14.2 188 19.0 257 17.4
Total 487 100.0 988 100.0 1,475 100.0
Table 16. Number of primary total knee arthroplasties per fixation technique by age group. Source RACat.
<65 65-74 75-84 >=85 Total
n % n % n % n % n %
Cemented 5,848 71.6 15,371 74.7 14,298 78.3 773 80.8 36,290 75.7
Cementless 145 1.8 185 0.9 103 0.6 7 0.7 440 0.9
Hybrid 1,374 16.8 3,286 16.0 2,340 12.8 83 8.7 7,083 14.8
Inverse hybrid 107 1.3 170 0.8 75 0.4 0 0.0 352 0.7
Not specified 692 8.5 1,560 7.6 1,441 7.9 94 9.8 3,787 7.9
Total 8,166 100.0 20,572 100.0 18,257 100.0 957 100.0 47,952 100.0
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Table 17. Number of primary partial knee arthroplasties per fixation technique by age group. Source RACat.
<65 65-74 75-84 >=85 Total
n % n % n % n % n %
Cemented 505 75.0 469 86.9 220 89.1 13 92.9 1,207 81.8
Cementless 7 1.0 1 0.2 3 1.2 0 0.0 11 0.8
Not specified 162 24.0 70 13.0 24 9.7 1 7.1 257 17.4
Total 674 100.0 540 100.0 247 100.0 14 100.0 1,475 100.0
Table 18. Number of primary total knee arthroplasties by fixation technique. Source RACat
CR PS Constrained Tumoral Hinge Rotational Total
n % n % n % n % n % n % n %
Cemented 14,067 63.8 21,737 88 424 80.5 0 0.0 58 42.7 4 0.9 36,290 75.7
Cementless 292 1.3 148 1 0 0.0 0 0.0 0 0.0 0 0.0 440 0.9
Inverse 
hybrid
190 0.9 162 1 0 0.0 0 0.0 0 0.0 0 0.0 352 0.7
Hybrid 5,384 24.4 1,665 7 32 6.1 2 12.5 0 0.0 0 0.0 7,083 14.8
Not 
specified
2,111 9.6 1,065 4 71 13.5 14 87.5 78 57.4 448 99.1 3,787 7.9
Total 22,044 100.0 24,777 100 527 100.0 16 100.0 136 100.0 452 100.0 47,952 100.0
CR: Posterior cruciate retaining; PS: Posterior stabilized
Table 19. Number of primary partial knee arthroplasties by fixation technique. Source: RACat
Patellofemoral Bicompartmental Unicompartmental Total
n % n % n % n %
Cemented 15 93.8 7 100 1,185 96.9 1,207 81.8
Cementless 0 0.0 0 0 11 0.9 11 0.8
Not specified 225 93.8 0 0 27 2.2 252 17.4
Total 240 100.0 7 100 1,223 100.0 1,470 100.0
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4.4. Characteristics of implant models
In the period 2005-2014, from all the prosthesis correctly classified, a total of 137 models (count-
ing the cemented and cementless models separately) were identified. Figure 10 shows the 
variability in the usage of different prosthesis models in the hospitals participating in the RACat. 
As a general trend, there is a tendency towards use of a wider range of models as the number 
of arthroplasties performed in the hospital rises. In primary knee arthroplasties, the number of 
models used per hospital ranged from 1 to 38, with an average of 12. 
The five most frequent implant models by type of fixation and by type of knee arthroplasty are 
described in Table 20 and Table 21, respectively. NEXGEN was the most common cemented 
implant across the study period. Models for cementless and inverse hybrid prosthesis showed 
some variation over the study periods, GEMINI LINK being the most used model in both groups 
during the period 2013-2014. For hybrid prosthesis, ADVANCE model was used mainly during 
the period 2005-2012, but SIGMA increased during the latter period. 
Figure 10. Number of different prosthesis models in relation to the volume of primary knee arthroplasties in 
the 2005-2014 period. Source RACat.
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Table 20. Five most frequent models in primary knee arthroplasty per fixation type and period. Source RACat.
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014
Model n % Model n % Model n % Model n % Model n %
Cemented
NEXGEN cim 743 22.3 NEXGEN cim 1,735 24.7 NEXGEN cim 1,642 17.1 NEXGEN cim 1,680 18.1 NEXGEN cim 1,692 20.5
PROFIX cim 386 11.6 SIGMA cim 809 11.5 PROFIX cim 1,348 14.0 PROFIX cim 1,113 12.0 GENUTECH cim 1,170 14.1
SCORPIO cim 334 10.0 PROFIX cim 689 9.8 GENUTECH cim 1,015 10.6 GENUTECH cim 999 10.8 SIGMA cim 1,154 14.0
ADVANCE cim 312 9.4 SCORPIO cim 571 8.1 SCORPIO NRG cim 884 9.2 SIGMA cim 740 8.0 TRIATHLON cim 891 10.8
OPTETRAK cim 266 8.0 GENUTECH cim 416 5.9 SIGMA cim 833 8.7 TRIATHLON cim 921 10.0 LEGION cim 549 6.6
Cementless
TRI CCC 17 43.6 TRI CCC 22 31.9 ALPINA 97 41.6 TRI CCC 25 28.7 GEMINI LINK 11 47.8
SKS 11 28.2 SKS 21 30.4 VANGUARD 45 19.3 VANGUARD ROCC 16 18.4 INNEX 3 13.0
EMOTION 6 15.4 EMOTION 17 24.6 TRI CCC 30 12.9 GEMINI LINK 13 14.9 PROFIX 1 4.4
UKS 3 7.7 NEXGEN 4 5.8 SKS 22 9.4 SKS 10 11.5 TRI CCC 1 4.4
PROFIX 2 5.1 UKS 3 4.4 GENESIS II 13 5.6 ALPINA 8 9.2 VANGUARD ROCC 7 30.4
Hybrid
ADVANCE 696 62.6 ADVANCE 601 36.0 ADVANCE 688 34.9 ADVANCE 521 37.8 SIGMA 311 32.4
913 139 12.5 AGC 455 27.3 AGC 546 27.7 GENUTECH 332 24.1 GENUTECH 298 31.0
GENUTECH 89 8.0 GENUTECH 194 11.6 SIGMA 265 13.5 SIGMA 214 15.5 ADVANCE 172 17.9
SIGMA 77 6.9 SIGMA 106 6.4 GENUTECH 100 5.1 AGC 68 4.9 UKNEE 82 8.5
UKNEE 30 2.7 913 77 4.6 VANGUARD 72 3.7 UKNEE 61 4.4 VANGUARD 26 2.7
Inverse hybrid
GEMINI LINK cim 35 70.0 GEMINI LINK cim 54 40.9 NEXGEN cim 38 36.9 GEMINI LINK cim 21 29.2
NEXGEN cim 10 20.0 NEXGEN cim 50 37.9 VANGUARD cim 33 32.0 NEXGEN LPS FLEX 
cim
1 1.4
EMOTION cim 1 2.0 VANGUARD cim 18 13.6 GEMINI LINK cim 25 24.3 NEXGEN cim 35 48.6
PROFIX cim 1 2.0 ALPINA cim 3 2.3 HLS UNI EVOLU-
TION cim
3 2.9 VANGUARD cim 15 20.8
SCORPIO cim 1 2.0 NEXGEN LPS FLEX 
cim
3 2.3 PROFIX cim 1 1.0 0 0.0
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Table 21. Five most frequent models in primary knee arthroplasty per type of arthroplasty and period. Source RACat.
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014
Model n % Model n % Model n % Model n % Model n %
CR
ADVANCE 400 19.4 PROFIX cim 710 18.3 PROFIX cim 1,313 23.2 PROFIX cim 1,090 19.5 SIGMA cim 977 20.1
PROFIX cim 385 18.7 SIGMA cim 619 16.0 SIGMA cim 610 10.8 VANGUARD cim 705 12.6 VANGUARD cim 692 14.3
SIGMA cim 170 8.3 ADVANCE 389 10.0 ADVANCE 425 7.5 SIGMA cim 558 10.0 GENUTECH cim 523 10.8
913 139 6.8 AGC 268 6.9 GENUTECH cim 338 6.0 GENUTECH cim 382 6.8 TRIATHLON cim 339 7.0
SCORPIO cim 129 6.3 GENUTECH 195 5.0 AGC 280 5.0 GENUTECH 326 5.8 SIGMA 317 6.5
PS
NEXGEN cim 665 27.7 NEXGEN cim 1,616 31.9 NEXGEN cim 1,556 23.7 NEXGEN cim 1,675 28.7 NEXGEN cim 1,688 34.5
ADVANCE 295 12.3 SCORPIO cim 485 9.6 SCORPIO NRG cim 942 14.3 TRIATHLON cim 662 11.3 GENUTECH cim 588 12.0
SCORPIO cim 208 8.7 GENUTECH cim 384 7.6 GENUTECH cim 715 10.9 GENUTECH cim 601 10.3 TRIATHLON cim 559 11.4
OPTETRAK cim 184 7.7 SCORPIO NRG cim 270 5.3 TRIATHLON cim 467 7.1 GENESIS II cim 393 6.7 LEGION cim 397 8.1
ALPINA cim 181 7.5 SIGMA cim 233 4.6 GENESIS II cim 333 5.1 NEXGEN GSF cim 357 6.1 VANGUARD cim 319 6.5
Constrained
PERFORMANCE 
cim
15 35.7 NEXGEN cim 45 43.3 NEXGEN cim 29 22.0 NEXGEN cim 27 29.0 GENUTECH cim 66 42.3
NEXGEN cim 8 19.1 PERFORMANCE 
cim
21 20.2 GENUTECH cim 27 20.5 GENUTECH cim 21 22.6 TRIATHLON cim 27 17.3
SCORPIO cim 7 16.7 SCORPIO cim 13 12.5 SCORPIO cim 20 15.2 GENESIS II cim 8 8.6 NEXGEN cim 23 14.7
ADVANCE cim 5 11.9 913 cim 10 9.6 PERFORMANCE 
cim
16 12.1 TRIATHLON cim 7 7.5 GENUTECH 18 11.5
SIGMA TC3 cim 4 9.5 GENUTECH cim 7 6.7 LEGION cim 12 9.1 PERFORMANCE 
cim
6 6.5 LEGION cim 11 7.1
Tumoral PSO 2 100.0 STANMORE cim 1 100.0 METS 5 100.0 METS 7 100.0
Hinge
ENDO-MODEL 
LINK cim
1 33.3 ROTAX cim 11 45.8 ENDO-MODEL-M 11 25.0 ENDO-MODEL-M 9 36.0 ENDO-MODEL-M 15 37.5
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2005/2006 2007/2008 2009/2010 2011/2012 2013/2014
Model n % Model n % Model n % Model n % Model n %
NOILES cim 1 33.3 ENDO-MODEL-M 5 20.8 NEXGEN cim 8 18.2 MRH cim 3 12.0 NEXGEN cim 9 22.5
ROTAX cim 1 33.3 GMRS cim 2 8.3 RHK cim 8 18.2 OSS cim 3 12.0 MEGASYS-
TEM-C LINK cim
8 20.0
NOILES cim 2 8.3 ROTAX cim 7 15.9 MEGASYSTEM-C 
LINK cim
2 8.0 OSS cim 3 7.5
NEXGEN cim 1 4.2 MRH cim 4 9.1 METS cim 2 8.0 NOILES cim 2 5.0
Rotational
ENDO-MODEL 
LINK cim
24 100.0 ENDO-MODEL LINK 
cim
116 100.0 ENDO-MODEL LINK 
cim
128 98.5 ENDO-MODEL LINK 
cim
83 97.7 ENDO-MODEL 
LINK cim
97 100.0
RHK cim 2 1.5 PROFIX cim 1 1.2
RHK cim 1 1.2
Patellofemoral
MIS AVON cim 1 50.0 ACCURIS cim 2 4.4 COMPETITOR cim 36 46.2 COMPETITOR cim 47 64.4 COMPETITOR 
cim
24 58.5
SPHEROCEN-
TRIC cim
1 50.0 COMPETITOR cim 34 73.9 FPV cim 13 16.7 PFJ cim 9 12.3 VANGUARD PFC 
cim
6 14.6
Inverse hybrid MIS AVON cim 5 10.9 ACCURIS cim 8 10.3 FPV cim 6 8.2 FPV cim 5 12.2
SPHEROCENTRIC 
cim
4 8.7 PFJ cim 5 6.4 ACCURIS cim 5 6.9 PFJ cim 2 4.9
VANGUARD PFC 
cim
1 2.2 SPHEROCENTRIC 
cim
2 2.7
Bicompartmental
JOURNEY DEUCE 
cim
1 100.0 JOURNEY DEUCE 
cim
6 100.0
Unicompartmental
ZIMMER UNI 
KNEE cim
26 25.5 ZIMMER UNI KNEE 
cim
54 30.7 ACCURIS cim 110 37.5 ACCURIS cim 156 58.2 ACCURIS cim 253 65.9
ACCURIS cim 25 24.5 ACCURIS cim 50 28.4 OXFORD III cim 76 25.9 OXFORD III cim 54 20.2 SIGMA cim 64 16.7
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2005/2006 2007/2008 2009/2010 2011/2012 2013/2014
Model n % Model n % Model n % Model n % Model n %
OXFORD III cim 16 15.7 OXFORD III cim 42 23.9 ZIMMER UNI KNEE 
cim
54 18.4 TRIATHLON cim 21 7.8 OXFORD III cim 51 13.3
MILLER/GAL-
LAN- TE cim
13 12.8 ENDO-MODEL 
LINK cim
14 8.0 ENDO-MODEL 
LINK cim
15 5.1 SIGMA cim 11 4.1 TRIATHLON cim 6 1.6
ADVANCE cim 10 9.8 EIUS cim 7 4.0 COMPETITOR cim 13 4.4 ZIMMER UNI KNEE 
cim
9 3.4 OXFORD cim 4 1.0
Percentages were calculated for each model out of total prosthesis used in each type of arthroplasty. Only the values of the 5 most common models are shown in the table, which 
explains that for some types of arthroplasties percentages do not add up to 100.
CR: Posterior cruciate retaining; PS: Posterior stabilized
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4.5. Implant survival in knee arthroplasties
Follow-up description
The median length of follow-up from the date of primary arthroplasty until the revision surgery 
or censorship was 4.22 years (SD: 2.48) and 3.48 years (SD: 2.37) for total and partial arthro-
plasties, respectively. Figure 11 shows the distribution of follow-up time for patients undergoing 
total and partial knee arthroplasty. 
Figure 11. Distribution of the follow-up time of the patients with primary knee arthroplasties. A) Total;  
B) Partial. Source: RACat.
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Cumulative revision rate
The estimated cumulative revision rate for total and partial knee arthroplasties (with no adjust-
ment) is shown in Table 22 and Table 23. For total knee arthroplasties, the 1-year revision rate 
was 0.89%, rising to 3.8% at 5-year and 5.1% at 9-years after the primary surgery. For partial 
knee arthroplasties, the rate was 2.0% and 10.2% at the 1-year and 5-year after the primary 
surgery, respectively. 
The risk of revision both for patients who underwent total and partial knee arthroplasty was 
adjusted by sex, age, and comorbidities. A higher risk of revision was observed in groups of 
younger patients. The Cox model fitted for total knee arthroplasties revealed an increased risk 
of revision for patients under 65 years and for patients aged between 65 and 75 years com-
pared to those aged 85 years or over (HR=3.34 (IC95%: 1.96-5.70); HR=2.02 (IC95%: 1.19-
3.43); data not shown). A similar trend was observed for partial knee arthroplasties, although 
differences were not statistically significant (data not shown).
The cumulative revision rate by fixation technique (without adjustment) for total knee arthroplas-
ties revealed that cemented and hybrid prostheses showed the lowest revision rate at 1-year 
(0.8% and 0.7%, respectively), whereas the 1-year revision rate for cementless prosthesis was 
3.0% (Table 24, Figure 12). For partial knee arthroplasties, the cumulative revision rate for 
cemented prosthesis was 2.0% at 1-year follow up, rising to 7.4% and 10.1% at 3- and 5-year 
follow-up, respectively (Table 25). Estimating the risk of revision of total knee arthroplasties per 
fixation technique using a Cox model (adjusted by sex, age and comorbidities), revelated a 
higher risk of revision of cementless and inverse hybrid arthroplasties in comparison with 
cemented arthroplasties (HR=2.00 (IC95%: 1.43-2.81); HR=1.58 (IC95%: 1.01-2.46), respec-
tively). However, the risk of revision was lower among prosthesis using hybrid fixation (HR=0.69 
(IC95%: 0.59-0.81; data not shown).
Table 26 shows the cumulative revision rates for CR and PS, the two most common types of 
total knee arthroplasty. The data shows  that the cumulative rate at 1- and 3-year of follow-up is 
quite similar between both arthroplasty types. However, the 9-year cumulative rate was some-
what higher for PS in comparison to CR. The cumulative revision rate for partial knee arthroplas-
ties revealed that 1-year revision rate for unicompartmental arthroplasties was 2.1%, increasing 
up to 7.0% and 9.3% at 3- and 5-year follow-up, respectively (Table 27). Risk of revision adjusted 
by sex, age and comorbidities for CR and PS arthroplasties revealed no differences in the risk 
of revision for both types of arthroplasties (data not shown). 
We estimated the cumulative incidence of replacement considering death as a competitive 
event, both for partial and total knee arthroplasties. Figure 13 shows two functions: one with the 
cumulative risk of revision adjusted by age, sex, comorbidity and patient death probability, and 
the other adjusted by the same variables without considering the competitive risk of death. It can 
be observed that both curves are quite similar, the cumulative incidence function without adjust-
ment by competitive risk of death slowly growing apart from the other curve. Even though the 
difference is not very significant, it increases over time and 4-5 years after the intervention, the 
difference becomes more evident. For total knee arthroplasty, the cumulative incidence of revi-
sion, adjusted by age, sex, and comorbidity at 5 years was 4.02% and considering competitive 
risk of death, 3.99%. For partial knee arthroplasties, the cumulative incidence of revision, 
adjusted by age, sex, and comorbidity at 5 years was 10.74% and considering competitive risk 
of death, 10.65%
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Table 22. Estimated cumulative revision rate after a primary total knee arthroplasty. Source: RACat-MBD-
SHD-RCA
Time
Primary arthro-
plasty
Revisions
Cumulative 
revision rate 
(%)
CI 95%
30 days 45,019 76 0.17 0.13 0.21
90 days 43,934 101 0.39 0.34 0.46
1 year 40,289 209 0.89 0.81 0.98
3 years 28,832 671 2.77 2.61 2.94
5 yeas 16,812 266 3.84 3.63 4.05
7 years 7,546 91 4.53 4.29 4.79
9 years 790 26 5.17 4.76 5.63
95%CI: 95% confidence interval. RACat: Catalan Arthroplasty Register
Table 23. Estimated cumulative revision rate after a primary partial knee arthroplasty. Source: RACat-MBD-
SHD-RCA.
Time
Primary arthro-
plasty
Revisions
Cumulative 
Revision rate 
(%)
CI 95%
30 days 1,387 1 0.07 0.01 0.51
90 days 1,339 1 0.15 0.04 0.58
1 year 1,134 22 2.07 1.41 3.02
3 years 706 54 7.55 6.1 9.34
5 years 391 18 10.24 8.42 12.43
7 years 136 4 11.6 9.44 14.22
9 years 12 2 . . .
95%CI: 95% confidence interval. RACat: Catalan Arthroplasty Register
Estimates in italics indicate that fewer of 250 remain at risk of revision at the time shown. Blank cells indicate that the 
number at risk at the time shown is fewer than 100 cases. In that case, estimates were not calculated since they are 
very unreliable.
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Table 24. Estimated cumulative revision rate after a primary total knee arthroplasty by fixation technique. 
Source: RACat- MBDSHD-RCA
Time
Primary 
arthroplasty
Revisions
Cumulative 
Revision rate 
(%)
CI 95%
Cemented
30 days 34,145 60 0.18 0.14 0.23
90 days 33,296 77 0.40 0.34 0.47
1 year 30,428 143 0.86 0.77 0.97
3 years 21,380 515 2.8 2.61 3
5 years 12,113 207 3.92 3.69 4.18
7 years 5,535 73 4.7 4.4 5.01
9 years 379 22 5.62 4.95 6.37
Cementless
30 days 400 0 0.00 . .
90 days 400 0 0.00 . .
1 year 385 12 3.02 1.73 5.26
3 years 316 17 7.5 5.27 10.62
5 years 171 6 9.5 6.89 13.02
7 years 51 0 . . .
9 years 1 0 . . .
Hybrid 
30 days 6,669 6 0.09 0.04 0.2
90 days 6,564 8 0.21 0.12 0.35
1 year 6,176 30 0.68 0.51 0.91
3 years 5,014 87 2.18 1.84 2.58
5 years 3,417 32 2.87 2.46 3.34
7 years 1,622 12 3.31 2.84 3.85
9 years 385 4 3.61 3.07 4.25
Inverse Hybrid 
30 days 344 0 0.00 . .
90 days 336 1 0.29 0.04 0.21
1 year 313 5 1.83 0.83 4.04
3 years 211 10 5.68 3.5 9.16
5 years 109 4 7.93 5.1 12.23
7 years 12 0 . . .
9 years 1 0 . . .
95%CI: 95% confidence interval. RACat: Catalan Arthroplasty Register
Estimates in italics indicate that fewer of 250 remain at risk of revision at the time shown. Blank cells indicate that the 
number at risk at the time shown is fewer than 100 cases. In that case, estimates were not calculated since they are 
very unreliable.
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Figure 12. Estimated cumulative revision rate after a primary total knee arthroplasty by fixation technique. 
Source: RACat-MBDSHD-RCA
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Table 25. Estimated cumulative revision rate after a primary partial knee arthroplasty by fixation technique. 
Source: RACat- MBDSHD-RCA
      Time
Primary arthro-
plasty
Revisions
Cumulative 
Revision rate 
(%)
CI 95%
Cemented
30 days 1,348 1 0.07 0.01 0.52
90 days 1,301 1 0.15 0.04 0.6
1 year 1,101 23 2.05 1.39 3.02
3 years 687 52 7.45 5.99 9.25
5 years 384 17 10.05 8.23 12.25
7 years 132 4 11.45 9.27 14.1
9 years 12 2 . . .
95%CI: 95% confidence interval. RACat: Catalan Arthroplasty Register
Estimates in italics indicate that fewer of 250 remain at risk of revision at the time shown. Blank cells indicate that the 
number at risk at the time shown is fewer than 100 cases. In that case, estimates were not calculated since they are 
very unreliable.
The number of patients at risk for the other fixation categories was <100; the estimates were not calculated since they 
were very unreliable.
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Table 26. Estimated cumulative revision rate after a primary total knee arthroplasty (CR/PS)
Time, in years
Primary arthro-
plasty
Revisions
Cumulative 
Revision rate 
(%)
CI 95%
CR
30 days 21,017 25 0.12 0.08 0.18
90 days 20,477 47 0.34 0.27 0.43
1 year 18,633 40 0.91 0.78 1.05
3 years 13,155 306 2.76 2.53 3.02
5 years 7,516 113 3.78 3.48 4.1
7 years 3,444 36 4.40 4.04 4.78
9 years 382 12 4.79 4.38 5.24
PS
30 days 23,168 45 0.19 0.14 0.26
90 days 22,660 49 0.41 0.33 0.5
1 year 20,918 94 0.84 0.73 0.96
3 years 15,140 350 2.73 2.51 2.97
5 years 8,969 145 3.81 3.54 4.11
7 years 3,996 54 4.59 4.25 4.96
9 years 405 14 5.46 4.77 6.24
95%CI: 95% confidence interval. RACat: Catalan Arthroplasty Register
CR: Posterior cruciate retaining; PS: Posterior stabilized
Table 27. Estimated cumulative revision rate after a primary partial knee arthroplasty (Unicompartmental/
Patellofemoral)
Time
Primary arthro-
plasty
Revisions
Cumulative 
Revision rate 
(%)
CI 95%
Unicompartmental
30 days 1,146 1 0.09 0.01 0.62
90 days 1,102 1 0.18 0.04 0.7
1 year 914 18 2.13 1.41 3.22
3 years 551 38 6.99 5.45 8.95
5 years 328 12 9.27 7.36 11.64
7 years 121 4 10.88 8.54 13.82
9 years 12 1 . . .
Patellofemoral
30 days 229 0 0.00 . .
90 days 226 0 0.00 . .
1 year 211 2 0.92 0.23 3.64
3 years 146 16 9.34 5.98 14.44
5 years 57 5 . . .
7 years 17 0 . . .
9 years 1 1 . . .
CI 95%: 95% confidence interval. RACat: Catalan Arthroplasty Register
Estimates in italics indicate that fewer of 250 remain at risk of revision at the time shown. Blank cells indicate that the 
number at risk at the time shown is fewer than 100 cases. In that case, estimates were not calculated since they are 
very unreliable.
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Figure 13. Cumulative incidence of revision after a primary total and partial knee arthroplasty adjusted by 
competitive risk of death, sex and age. A) Total knee arthroplasty; B) Partial knee arthroplasty. Source: 
RACat-RCA
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5. Hip Arthroplasties results
5.1. Scope and quality of the data
In the period described, data from 46,488 patients with primary hip arthroplasty and from 5,237 
patients with revision hip arthroplasty was received. The volume of data increased over time, 
suffering a slight decrease from 2012 onwards (Figure 14). The highest volume of primary and 
revision arthroplasties was registered in the health care region of Barcelona (Table 28).
Table 29 shows the volume of primary and revision arthroplasties sent during the study period, 
per centre. The overall burden of revision, understood as the percentage of revision arthroplas-
ties compared to the total number of events sent, was 11.3%. 
Figure 15 shows the completeness both for primaries and revisions over the study period. The 
data shows that the highest completeness was reached in 2011 and 2012. A gradual decrease 
was observed from 2012 onwards, coinciding with technical changes in data notification. Figure 
16 shows the variability in data completeness of each centre (blue points) compared with overall 
completeness (green line) and a confidence interval based on overall completeness. The cen-
tres that are below the range of the confidence interval exhibit lower completeness compared to 
the overall figure, and the ones that are above exhibit higher completeness than the overall. 
Twelve out of the 53 centres fell below the confidence interval based on the overall reference 
value. 
As shown in Table 30, in the latter period 77.1% of hip arthroplasties were classified. Figure 17 
is a funnel plot which shows the percentage of classified primary arthroplasties per centre in 
relation to the volume of data sent in the period 2013-2014. It can be observed great variability 
between centres on the percentage of classified cases, most of them presenting percentages 
around 80%, which indicates good quality of the information sent.  
The percentage of arthroplasties with reported laterality increased over the study period reach-
ing in 2013-2014 a 97.6% (Table 31). Using data from the latest 2 years we plotted percentage 
of laterality reported per centre (Figure 18). In that case, the percentage of completeness for this 
variable is high in most centres.  
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Figure 14. Volume of hip arthroplasties sent to the RAcat per year. Source: RACat
Table 28. Number of hip arthroplasties by health region, period and by type of arthroplasty. Source RACat.
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Lleida 90 19 248 26 332 33 535 28 587 16 1,792 122
Camp de Tarragona 86 1 458 26 771 49 745 57 709 71 2,769 204
Terres de l’Ebre 0 1 0 0 275 23 276 18 324 24 875 66
Girona 924 80 1,217 133 1,429 168 1,435 159 1,423 107 6,428 647
Catalunya Central 438 58 880 94 972 134 1,065 101 1,141 97 4,496 484
Alt Pirineu i Aragó 116 5 104 7 111 8 122 6 103 4 556 30
Barcelona 3,520 398 5,118 604 6,951 931 7,232 956 6,751 795 29,572 3,684
Total 5,174 562 8,025 890 10,841 1346 11,410 1325 11,038 1114 46,488 5,237
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Table 28 Number of hip arthroplasties by health region, period and by type of arthroplasty. Source RACat. 
 
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014 All periods 
 
Primary Revision Primary Revision Primary Revision Primary Revision Primary Revision Primary Revision 
LLEIDA 90 19 248 26 332 33 535 28 587 16 1,792 122 
CAMP DE TARRAGON 86 1 458 26 771 49 745 57 709 71 2,769 204 
TERRES DE L'EBRE 0 1 0 0 275 23 276 18 324 24 875 66 
GIRONA 924 80 1,217 133 1,429 168 1,435 159 1,423 107 6,428 647 
CATALUNYA CENTRA 438 58 880 94 972 134 1,065 101 1,141 97 4,496 484 
ALT PIRINEU I AR 116 5 104 7 111 8 122 6 103 4 556 30 
BARCELONA 3,520 398 5,118 604 6,951 931 7,232 956 6,751 795 29,572 3,684 
Total 5,174 562 8,0 5 890 10,841 1346 11,410 1325 11,038 1114 46,488 5,237 
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Primary 1458 3716 3868 4157 5086 5755 5472 5938 5517 5521
Revision	 151 411 414 476 598 748 716 609 522 592
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Table 29. Number of hip arthroplasties by health care region, centre, period and by type of arthroplasty. 
Source RACat.
Hospital 
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Lleida
Hospital Universitari Arnau de 
Vilanova
0 0 0 0 78 14 303 7 309 0 690 21
Hospital de Santa Maria 70 16 171 13 153 13 108 14 178 7 680 63
Clínica de Ponent 20 3 77 13 101 6 124 7 100 9 422 38
Camp de Tarragona
Hospital Universitari de Tarra-
gona Joan XXIII
0 0 147 12 211 24 207 33 214 30 779 99
Hospital Universitari Sant 
Joan de Reus
0 0 70 0 302 0 293 0 122 0 787 0
Hospital de Sant Pau i Santa 
Tecla
19 0 64 3 79 16 81 11 123 8 366 38
Pius Hospital de Valls 48 1 106 3 100 6 92 6 94 4 440 20
Hospital del Vendrell 19 0 71 8 79 3 72 7 156 29 397 47
Terres de l´Ebre
Hospital Tortosa Verge de la 
Cinta
0 1 0 0 275 23 219 18 270 24 764 66
Hospital Comarcal Móra 
d’Ebre
0 0 0 0 0 0 57 0 54 0 111 0
Girona
Hospital Universitari de 
Girona Josep Trueta
0 0 235 49 270 52 261 46 284 9 1,050 156
Clínica Girona SA 0 0 0 0 39 4 73 7 0 0 112 11
Clínica Salus Infirmorum 0 0 0 0 0 0 0 0 42 1 42 1
Hospital Comarcal de Blanes 298 24 306 36 298 24 270 15 325 24 1,497 123
Hospital de Campdevanol 38 2 41 1 41 0 48 1 52 0 220 4
Hospital de Figueres 107 8 257 15 278 32 247 38 113 11 1,002 104
Hospital de Palamós 204 20 226 16 193 21 195 23 212 34 1,030 114
Hospital de Sant Jaume 
d’Olot
146 16 36 2 131 13 150 18 164 14 627 63
Hospital Provincial Santa 
Caterina
131 10 116 14 179 22 191 11 231 14 848 71
Catalunya Central
Centre Hospitalari-ALTHAIA 203 42 452 63 451 98 470 80 506 71 2,082 354
Hospital General de Vic 129 2 161 1 237 3 314 2 400 0 1,241 8
Hospital de Sant Bernabé 0 0 41 3 74 9 85 2 107 15 307 29
Fundació Sanitaria d’Igualada 
FP
106 14 226 27 210 24 196 17 128 11 866 93
Alt Pirineu i Aran
Fundació Sant Hospital de la 
Seu d’Urgell
32 2 35 0 44 1 45 3 39 2 195 8
Hospital Comarcal del Pallars 30 2 34 6 26 3 27 2 8 2 125 15
Hospital de Puigcerdà 54 1 35 1 41 4 50 1 56 0 236 7
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Barcelona
Hospital de Viladecans 0 0 0 0 74 21 160 21 190 4 424 46
Hospital Universitari de 
Bellvitge
358 0 287 0 438 8 203 15 194 5 1,480 28
H.Universitari Germans Trias 
i Pujol
0 0 10 3 186 37 237 18 334 3 767 61
Hospital Clinic i Provincial de 
Barcelona
703 109 639 68 780 133 701 126 593 132 3,416 568
Hospital de L’Hospitalet - CSI 275 29 227 23 337 43 303 53 366 22 1,508 170
Hospital Dos de Maig de 
Barcelona - CSI
75 6 64 14 150 18 187 21 201 15 677 74
Hospital Mútua de Terrassa 0 0 256 51 363 74 304 54 90 21 1,013 200
Hospital de l’Esperit Sant 61 31 133 21 232 21 199 23 198 39 823 135
Corporació Sanitária Parc 
Taulí
184 35 431 96 451 92 422 92 276 61 1,764 376
Hospital de Sant Boi- Parc 
Sanitari St Joan de Deu
92 7 134 5 145 13 170 20 223 19 764 64
Hospital de Sant Celoni - 
Fundació privada
70 5 118 3 93 5 81 1 138 2 500 16
Hospital de Terrassa 0 0 184 36 223 39 211 23 259 40 877 138
Parc de Salut del Mar 95 12 0 0 506 57 674 110 0 0 1,275 179
Hospital General de 
Granollers
191 25 237 25 66 5 335 23 237 66 1,066 144
Hospital Municipal de 
Badalona
160 14 167 10 132 14 160 14 112 11 731 63
Hospital Residència Sant 
Camil
192 35 188 51 207 30 212 27 204 20 1,003 163
Hospital Sant Joan de Déu 
de Martorell
70 14 161 51 195 22 161 21 139 12 726 120
Hospital de Sant Joan de 
D`Esplugues Llob
0 0 0 0 0 0 0 1 0 0 0 1
Hospital Sant Rafael 0 0 0 0 179 53 155 30 134 30 468 113
F.G.S. Hospital de la Santa 
Creu i Sant Pau
0 0 1 0 362 44 664 82 728 90 1,755 216
H. de Plató 0 0 87 6 98 11 35 3 68 4 288 24
Hospital Universitari Sagrat 
Cor
244 32 392 43 371 40 380 45 402 102 1,789 262
Fundació Privada Hospital de 
Mollet
129 6 95 3 102 7 175 7 199 3 700 26
Hospital Comarcal de l’Alt 
Penedes
1 0 146 30 163 20 184 24 177 26 671 100
Hospital de Mataro 145 38 281 64 366 56 327 62 373 38 1,492 258
H. Universitari Vall d’Hebron 475 0 880 1 732 68 592 40 916 30 3,595 139
Total 5,174 562 8,025 890 10,841 1,346 1,141 1,325 11,038 1,114 46,488 5,237
56
Figure 15. Completeness of data sent to the RACat per year, and by type of arthroplasty. Source RACat-MBD-
SHD
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
Primary 61,6 70,5 66,5 68,2 68,2 82,5 84,4 84,1 75,5 69,4 
Revision 46,1 52,7 42,8 44,8 56,1 64,3 62,0 58,2 49,7 40,8 
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Figure 16. Percentage of completeness of primary hip arthroplasties per centre during the period 2013-2014. 
Source: RACat 
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Table 30. Number and percentages of classified primary hip arthroplasties reported by period. Source RACat
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014 Total
n % n % n % n % n % n %
Classified 2,916 56.4 5,872 73.2 8,889 82.0 9,839 86.2 8,509 77.1 36,025 77.5
Not classified 2,258 43.6 2,153 26.8 1,952 18.0 1,571 13.8 2,529 22.9 10,463 22.5
Total 5,174 100.0 8,025 100.0 10,841 100.0 11,410 100.0 11,038 100.0 46,488 100.0
Figure 17. Percentage of primary hip arthroplasties classified per centre according to the volume of data 
sent in the period 2013-2014. Source: RACat.
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Table 31. Number of hip arthroplasties with the operated side (left or right) reported by period. Source RACat.
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014 Total
n % n % n % n % n % n %
Reported 
operated side 
2,378 41.5 1,806 20.3 541 4.4 73 0.6 296 2.4 5094 9.9
Not reported 3,358 58.5 7,109 79.7 11,646 95.6 12,662 99.4 11,856 97.6 46,631 90.2
Total 5,736 100.0 8,915 100.0 12,187 100.0 12,735 100.0 12,152 100.0 51,725 100.0
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Figure 18. Percentage of primary and revision hip arthroplasty with operated side informed per centre, and 
in relation to data volume sent in the period 2013-2014. Source: RACat
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5.2. Demographic and patient treatment process profile
From this section onwards the results are presented by total and partial hip arthroplasties. 
The average age of patients who underwent a total hip arthroplasty was 68.5 years (standard 
deviation; SD: 11.2) and 84.8 years (SD: 7.2) for those underwent a partial hip arthroplasty; 
women 52.1% and 75.9% men respectively (Table 32 and Table 33).
In the time period spanning between 2005 and 2014, the age group distribution among patients 
undergoing a total hip arthroplasty and partial hip arthroplasty remained relativel unchanged 
(Figure 19). Over 80% of patients undergoing partial hip arthroplasty were aged 75 years or 
older. 
Table 34 and Table 35 show the demographic and patient treatment profile of patients who 
experienced a hip arthroplasty by study periods. The data shows  that the main reason for inter-
vention of total hip arthroplasties was osteoarthritis, whereas fracture was the main cause of 
intervention for partial hip arthroplasties. Mechanical complications were the main cause for 
revision both for total and partial hip arthroplasties. As expected by differences in patient’s age 
distribution, the percentage of patients with 1 or more comorbidities was higher for patients 
undergoing partial hip arthroplasties in comparison to those undergoing a total hip arthroplasty. 
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Table 32. Age and sex of patients undergoing a primary total hip arthroplasty by health care region and period. Source: RACat
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014 Total
Health care region n
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Lleida 80 69.2 (10.8) 40.0 183 67.1 (11.8) 42.1 259 66.8 (11.7) 46.7 254 70.2 (11.0) 46.5 269 69.5 (11.6) 44.2 1,045 68.9 (11.6) 44.9
Camp de Tarragona 45 70.9 (9.2) 51.1 241 67.2 (12.2) 50.6 339 67.7 (13.0) 45.7 317 68.0 (11.7) 46.1 398 67.4 (12.0) 49.8 1,340 67.8 (12.2) 48.0
Terres de l’Ebre 0 0 0.0 0 0 0.0 181 67.1 (13.5) 47.0 108 65.9 (13.4) 50.9 126 66.2 (10.8) 50.8 415 68.5 (12.7) 49.0
Girona 493 70.7 (10.4) 56.2 591 70.6 (11.2) 56.0 656 70.3 (12.0) 55.3 625 69.8 (12.0) 51.0 704 69.3 (11.2) 50.6 3,069 70.1 (11.5) 53.6
Catalunya centra 164 70.1 (10.7) 48.2 451 69.4 (10.7) 49.5 502 68.6 (12.8) 50.0 567 68.1 (11.9) 47.3 628 68.1 (11.5) 46.5 2,312 68.7 (11.8) 48.4
Alt Pirineu i Aran 64 73.7 (9.4) 60.9 72 71.7 (9.9) 55.6 73 75.2 (11.0) 63.0 58 70.7 (11.4) 43.1 65 70.5 (10.7) 49.2 332 72.5 (10.5) 54.7
Barcelona 1,175 68.2 (11.5) 54.8 2,448 68.5 (12.3) 54.2 3,733 68.0 (12.6) 53.2 4,199 68.5 (12.4) 53.6 3,244 67.8 (12.6) 51.5 14,799 68.3 (12.5) 53.3
Total 2,021 69.3 (11.1) 54.1 3,986 68.8 (12.0) 53.2 5,743 68.3 (112.6) 52.3 6,128 68.6 (12.3) 51.9 5,434
68.1
(12.2)
50.3 23,312 68.5 (11.2) 52.1
Table 33. Age and sex of patients undergoing a primary partial hip arthroplasty by health care region and period. Source: RACat
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014 Total
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Lleida 4 86.6 (4.9) 100.0 7 86.1 (9.9) 100.0 12 84.6 (3.6) 83.3 170 84.6 (7.8) 81.8 128 85.1 (6.7) 74.2 321 84.8 (7.2) 79.4
Camp de Tarragona 36 84.6 (7.5) 80.6 98 84.0 (8.3) 73.5 100 83.8 (8.2) 69.0 114 85.1 (6.8) 76.3 143 85.6 (7.5) 70.6 491 84.7 (7.6) 72.9
Terres de l’Ebre 0 0 0.0 0 0 0.0 86 84.5 (5.1) 83.7 103 83.8 (6.5) 78.6 91 85.3 (5.6) 79.1 280 84.5 (5.8) 80.4
Girona 140 85.8 (6.2) 78.6 90 86.5 (5.2) 81.1 212 84.9 (7.1) 75.9 320 84.8 (6.6) 79.1 356 84.9 (7.8) 75.6 1,118 85.1 (7.0) 77.5
Catalunya central 114 83.4 (6.5) 76.3 294 83.8 (6.7) 75.5 353 84.0 (7.4) 77.6 429 84.6 (7.4) 73.0 411 84.8 (6.9) 74.0 1,601 84.3 (7.1) 75.0
Alt Pirineu i Aran 16 83.2 (8.4) 68.8 23 86.8 (6.2) 87.0 31 86.7 (7.0) 67.7 59 84.5 (9.1) 76.3 32 84.0 (7.4) 81.3 161 85.5 (7.9) 76.4
Barcelona 585 84.0 (7.4) 76.9 1,374 84.2 (7.2) 78.2 2,352 84.4 (7.2) 74.9 2,516 85.3 (7.0) 75.8 1,914 85.4 (7.3) 74.7 8,741 84.6 (7.2) 75.8
Total 895 84.2 (7.1) 77.2 1,886 84.3 (7.1 77.8 3,146 84.4 (7.2) 75.3 3,711 85.1 (7.1) 76.1 3,075 85.3 (7.3) 74.7 12,713 84.8 (7.2) 75.9
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Figure 19. Age of patients undergoing a hip arthroplasty by period. A) Total hip arthroplasty; B) Partial hip 
arthroplasty. Source: RACat
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Table 34. Demographic and patient treatment profile of patients with primary and revision total hip arthro-
plasty by period. Source RACat-MBDSHD
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014
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n
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ev
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n
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n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Number
1,844 
(100)
78 
(100)
3,765 
(100)
118 
(100)
5,453 
(100)
246 
(100)
5,958 
(100)
207 
(100)
5,211 
(100)
128 
(100)
% of Women
1,002 
(4.3)
47 
(60.3)
1,996 
(53.0)
72 
(61.0)
2,857 
(52.4)
1,133 
(54.1)
3,085 
(51.8)
115 
(55.6)
2,615 
(50.2)
69 
(53.9)
Mean age (SD)
69.3 
(11.0)
73.0 
(12.2)
68.8 
(12.0)
73.7 
(12.1)
68.4 
(12.5)
73.4 
(11.2)
68.5 
(12.2)
72.7 
(12.4)
68.0 
(12.1)
72.9 
(12.2)
Cause of intervention
Osteoarthritis
1,431 
(77.6)
0
3,008 
(79.9)
0
4,418 
(81.0)
0
4,810 
(80.7)
0
4,256 
(81.7)
0
Fracture
228 
(12.4)
0
394 
(10.5)
0
565 
(10.4)
0
654 
(11.0)
0
481 
(9.2)
0
Other diagnostics
185 
(10.0)
0
363 
(9.6)
0
470 
(8.6)
0
494 
(8.3)
0
474 
(9.1)
0
Cause of revision
Mechanical 
complications
0
54 
(69.2)
0
81 
(68,6)
0
170 
(69.1)
0
149 
(72,0)
0
80 
(62.5)
Infection 0 9 (11.5) 0 8 (6.8) 0
30 
(12.2)
0 21 (10.1) 0
21 
(16.4)
Other diagnostics 0
15 
(19.2)
0
29 
(24.6)
0
46 
(18.7)
0 37 (17.9) 0
27 
(21.1)
Comorbidity
1 or more
955 
(51.8)
44 
(56.4)
1,927 
(51.2)
66 
(55.9)
3,205 
(58.8)
166 
(67.5)
3,752 
(63.0)
139 
(67.2)
3,329 
(63.9)
88 
(68.8)
Healthcare 
discharge
162 
(8.8)
9 
(11.5)
317 
(8.4)
21 
(17.8)
562 
(10.3)
54 
(22.0)
763 
(12.8)
44 (21.3)
652 
(12.5)
31 
(24.2)
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Table 35. Demographic a nd patient treatment profile of patients with primary and revision partial hip arthro-
plasty by period. Source RACat-MBDSHD
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014
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n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Number
790 
(100)
2 
(100)
1,817 
(100)
13 
(100)
2,953 
(100)
18 
(100)
3,659 
(100)
16 
(100)
2,973 
(100)
13 
(100)
% of Women
612 
(77.5)
2 
(100)
1,419 
(78.1)
7 
(53.9)
2,222 
(75.3)
14 
(77.8)
2,788 
(76.2)
10 
(62.5)
2,228 
(74.9)
11 
(84.6)
Mean age (SD)
84.2 
(7.0)
91.3 
(3.1)
84.4 
(7.0)
79.8 
(8.0)
84.5 
(7.2)
82.8 
(9.4)
85.1 
(7.1)
85.0 
(7.1)
85.3 
(7.2)
84.7 
(6.0)
Cause of intervention
Fracture
752 
(95.2)
0
1,724 
(94.9)
0
2,799 
(94.8)
0
3,504 
(95.8)
0
2,841 
(95.6)
0
Other diagnostics 38 (4.8) 0 93 (5.1) 0
154 
(5.2)
0
152 
(4.3)
0
132 
(4.4)
0
Cause of revision
Mechanical 
complications
0
1 
(50.0)
0
7 
(53.9)
0
14 
(77.8)
0
10 
(62.5)
0
6 
(46.2)
Infection 0 0 0
4 
(30.8)
0 1 (5.6) 0
2 
(12.5)
0
6 
(46.2)
Other diagnostics 0
1 
(50.0)
0
2 
(15.4)
0
3 
(16.7)
0
4 
(25.0)
0
1 
(7.69)
Comorbidity
1 or more
560 
(70.9)
1 
(50.0)
1,356 
(74.6)
7 
(53.9)
2,289 
(77.5)
16 
(88.9)
3,047 
(83.3)
14 
(87.5)
2,057 
(84.3)
11 
(84.6)
Healthcare 
discharge
191 
(24.2)
1 
(50.0)
475 
(26.1)
0 
(0.0)
945 
(32.0)
3 
(16.7)
1,342 
(36.7)
6 
(37.5)
1,253 
(42.2)
6 
(46.6)
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5.3. Characteristics of primary arthroplasties
30,031 hip arthroplasties could be classified for the whole study period. Total hip arthroplasties 
represented 77.6% whereas partial arthroplasties represented 22.4%. Within total hip arthro-
plasties, the most common implants were the conventional prosthesis, representing over 95% 
of arthroplasties. Bipolar and unipolar monoblock were the most common types of partial pros-
thesis, representing 46.7% and 47.2% of partial arthroplasties, respectively (Table 36).  
Conventional total hip arthroplasties were the most common arthroplasty type across age 
groups. However, for partial hip arthroplasties, the use of bipolar prosthesis decreased propor-
tionally as  age increased, whereas the opposite pattern was observed for unipolar monoblock 
prosthesis (Figure 20). 
Almost 65% of total hip arthroplasties were cementless, this type of fixation showing an increas-
ing trend over time (Figure 21). The proportion of cemented and cementless prosthesis for 
partial hip arthroplasties was 49.5% and 50.5%, respectively. (Table 37, Table 38, and Figure 
21). Among total hip arthroplasties, the percentage of cementless prosthesis was higher for 
men than for women (73.1% and 57.4%, respectively) (Table 39). Regarding partial hip arthro-
plasties, the distribution of type of fixation for men and women was  quite similar (Table 40). 
Table 41 and Table 42 show the distribution of type of fixation technique by age groups, for total 
and partial arthroplasties, respectively. For total fixation techniques, the data shows that the 
percentage of cementless prostheses decreased proportionally as age increased. However, for 
partial hip arthroplasties, the older the patients, the higher the percentage of cementless pros-
theses. 
In conventional total hip arthroplasties, the most commonly used friction device was metal-pol-
yethylene (65.8%). This type of friction device was the most common in all age groups, even 
though there was more variability in the friction device used among patients under 65 (Table 43).
Head size distribution for total conventional hip arthroplasties by friction devices revealed that 
small heads (<32mm) were commonly used among Metal on Polyethylene and Ceramic on 
Polyethylene implants (72.7% and 68.1%, respectively). Medium heads were the most common 
among Ceramic on Ceramic arthroplasties (71%). Among Metal on Metal prosthesis, small 
heads represented 43.3% and large heads 35.7% (Table 44). 
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Table 36. Number of primary hip arthroplasties per type of arthroplasty and period. Source: RACat.
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014 Total
n % n % n % n % n % n %
Total Hip Arthroplasty
Double mobility 0 0.00 0 0.00 2 0.03 14 0.2 15 0.3 31 0.1
Resurfacing 23 1.1 124 3.1 234 4.1 121 2.0 46 0.9 548 2.4
Conventional 1,996 98.8 3,835 96.2 5,382 93.7 5,841 95.3 5,176 95.3 22,230 95.4
Short stem 2 0.1 27 0.7 125 2.2 152 2.5 197 3.6 503 2.2
Partial Hip Arthroplasty
Bipolar 339 37.9 818 43.4 1,617 51.4 1,668 45 1,491 48.5 5,933 46.7
Unipolar modular 96 10.7 132 7.0 231 7.3 207 5.6 114 3.7 780 6.14
Unipolar monoblock 460 51.4 936 49.6 1,298 41.3 1,836 49.5 1,470 47.8 6,000 47.2
Not specified 2,258 100.0 2,153 100.0 1,952 100.0 1,571 100.0 2,529 100.0 10,463 100.0
Total 5,174 100.0 8,025 100.0 10,841 100.0 11,410 100.0 11,038 100.0 46,488 100.0
Figure 20. Percentage distribution of primary hip arthroplasties by age group and type of arthroplasty. A) Total 
hip arthroplasty; B) Partial hip arthroplasty. Source RACat.
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Table 37. Number of primary total hip arthroplasties per fixation technique by time period. Source: RACat
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014 Total
n % n % n % n % n % n %
Cemented 324 16.0 438 11.0 497 8.7 654 10.7 483 8.9 2,396 10.3
Cementless 1,065 52.7 2,408 60.4 3,798 66.1 4,049 66.1 3,809 70.1 15,129 64.9
Hybrid 571 28.3 990 24.8 1,214 21.1 1,243 20.3 997 18.4 5,015 21.5
Inverse 
hybrid
61 3.0 150 3.8 230 4.0 176 2.9 130 2.4 747 3.2
Not specified 0 0.0 0 0.0 4 0.1 6 0.1 15 0.3 25 0.1
Total 2,021 100.0 3,986 100.0 5,743 100.0 6,128 100.0 5,434 100.0 23,312 100.0
Table 38. Number of primary partial hip arthroplasties per fixation technique by time period. Source: RACat
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014 Total
n % n % n % n % n % n %
Cemented 479 53.5 972 51.5 1,694 53.9 1,728 46.6 1,420 46.2 6,293 49.5
Cementless 416 46.5 914 48.5 1,452 46.2 1,983 53.4 1,654 53.8 6,419 50.5
Not specified 0 0.0 0 0.0 0 0.0 0 0.0 1 0.0 1 0.0
Total 895 100.0 1,886 100.0 3,146 100.0 3,711 100.0 3,075 100.0 12,713 100.0
Table 39. Number of primary total hip arthroplasties per fixation technique and sex. Source RACat.
Men Women Total
n % n % n %
Cemented 677 6.1 1,719 14.2 2,396 10.3
Cementless 8,165 73.1 6,964 57.4 15,129 64.9
Hybrid 1,805 16.2 3,210 26.5 5,015 21.5
Inverse hybrid 510 4.6 237 2.0 747 3.2
Not specified 20 0.2 5 0.0 25 0.1
Total 11,177 100.0 12,135 100.0 23,312 100.0
Table 40. Number of primary partial hip arthroplasties per fixation technique and sex. Source RACat.
Men Women Total
n % n % n %
Cemented 1,542 50.3 4,751 49.2 6,293 49.5
Cementless 1,521 49.6 4,898 50.8 6,419 50.5
Not specified 1 0.0 0 0.0 1 0.0
Total 3,064 100.0 9,649 100.0 12,713 100.0
Table 41. Number of primary total hip arthroplasties per fixation technique by age group. Source RACat.
<65 years 65-74 years 75-84 years >=85 years Total
n % n % n % n % n %
Cemented 99 1.3 363 5.0 1,611 21.7 323 35.2 2,396 10.3
Cementless 6,682 86.0 5,021 69.7 3,179 42.8 247 26.9 15,129 64.9
Hybrid 468 6.0 1,725 23.9 2,509 33.8 313 34.1 5,015 21.5
Inverse hybrid 500 6.4 92 1.3 121 1.6 34 3.7 747 3.2
Not specified 17 0.2 4 0.1 4 0.1 0 0.0 25 0.1
Total 7,766 100.0 7,205 100.0 7,424 100.0 917 100.0 23,312 100.0
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Figure 21. Percentage distribution of the fixation technique of primary hip arthroplasties by time period. 
A) Total arthroplasties; B) Partial arthroplasties. Source RACat
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Table 42. Number of primary partial hip arthroplasties per fixation technique by age group. Source RACat
<65 years 65-74 years 75-84 years >=85 years Total
n % n % n % n % n %
Cemented 148 77.1 560 74.2 3,041 59.9 2,544 38.1 6,293 49.5
Cementless 43 22.4 195 25.8 2,039 40.1 4,142 62.0 6,419 50.5
Not specified 1 0.5 0 0.0 0 0.0 0 0.0 1 0.0
Total 192 100.0 755 100.0 5,080 100.0 6,686 100.0 12,713 100.0
Table 43. Number of total conventional primary hip arthroplasties by type of friction device per age groups. 
Source RACat
<65 years 65-74 years 75-84 years >=85 years Total
n % n % n % n % n %
Metal on Metal 544 8.0 238 3.4 241 3.3 56 6.2 1,079 4.9
Metal on Polyethylene 2,867 42.0 5,000 70.4 6,026 81.5 741 81.3 14,634 65.8
Ceramic on Ceramic 1,301 19.1 328 4.6 104 1.4 6 0.7 1,739 7.8
Ceramic on Polyethylene 1,321 19.4 861 12.1 413 5.6 24 2.6 2,619 11.8
Ceramic on Metal 102 1.5 35 0.5 7 0.1 2 0.2 146 0.7
Metal on Polycarbonate 1 0.01 3 0.04 2 0.03 0 0 6 0.03
Not specified 691 10.1 637 9.0 597 8.1 82 9.0 2,007 9.0
Total 6,827 100 7,102 100 7,390 100 911 100 22,230 100
Table 44. Distribution of friction device per head size among conventional hip arthroplasties. Source RACat
Metal on Metal
Metal on Polyeth-
ylene
Ceramic on 
Ceramic
Ceramic on  
Polyethylene
Ceramic on Metal
n % n % n % n % n %
<32 mm 467 43.3 10,639 72.7 409 23.5 1,773 68.1 67 45.9
32-36mm 227 21.0 3,892 26.6 1,234 71.0 830 31.9 73 50.0
>36 mm 385 35.7 99 0.7 96 5.5 1 0.04 6 4.1
Total 1,079 100 14,630 100 1,739 100 2,604 100 146 100
Information on the head size was not available in 2,032 cases, representing 9.1% of conventional hip arthroplasties. 
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5.4. Characteristics of implant models
In the period 2005-2014, a total of 1,114 models of stem-socket combinations (counting sepa-
rately the cemented and uncemented models. Ex. Evoris cim and Evoris) were identified. In 
primary total hip arthroplasties, the number of acetabular models used by the hospitals ranged 
from 1 to 34, with an average of 16 per hospital. As for stem models, the number ranged from 1 
to 33 with an average of 15 models used per hospital. As observed for knee arthroplasties, the 
number of implanted models grows in proportion to  an increase in the volume of arthroplasties 
per centre (Figure 22). 
Table 45 shows the five most frequent models in primary hip arthroplasty per type of arthroplasty 
and period. In the case of total hip arthroplasties, each model is presented as the combination 
of stem and socket component, and in the partial hip arthroplasties the stem model and the 
manufacturer are specified. 
Figure 22. Number of different prostheses models in relation to the volume of primary hip arthroplasties for 
each centre sent to the RACat in the 2013-2014 period. Source: RACat
Both total and partial arthroplasties were considered. 
Figure 22.  
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Table 45. Five most frequent models in primary hip arthroplasty per type of arthroplasty and period. Source: RACat
2005/2006 2007/2008 2009/2010 2011/2012 2013/2014
Model n % Model n % Model n % Model n % Model n %
Double mobility (stem/cup)
FURLONG/
NOVAE E 
2 100.0
FURLONG/
POLARCUP
3 21.4
SHINE-C cim/
DMX 
8 53.3
A-ACUTA S/
POLARCUP
2 14.3
FURLONG/
DOUBLE MOBILITY
2 13.3
AUTOBLOQUEANTE 
cim/NOVAE E
1 7.1
 POLARSTEM/
POLARCUP
2 13.3
EXETER cim/ 
NOVAE E
1 7.1
SHINE-C cim/
DUAL cim
2 13.3
FURLONG/
NOVAE E
1 7.1
FURLONG/
DOUBLE MOBILITY
1 6.7
Resurfacing (head/cup)
ASR/ASR 13 56.5 ASR/ASR 37 29.8 RECAP/RECAP 63 26.9 RECAP/RECAP 33 27.3
CONSERVE PLUS/
CONSERVE
23 50.0
CONSERVE PLUS/
CONSERVE
5 21.7 RECAP/RECAP 33 26.6
CONSERVE 
PLUS/
CONSERVE
47 20.1
DUROM/
MMC
25 20.7 ICON TM/ICON TM 13 28.3
BHR/BHR 4 17.4
CONSERVE PLUS/
CONSERVE
18 14.5
CORMET/
CORMET
45 19.2
CONSERVE PLUS/
CONSERVE
23 19.0 RECAP/RECAP 7 15.2
RECAP/RECAP 1 4.4 ICON TM/ICON TM 16 12.9 ADEPT/ADEPT 22 9.4 CORMET/CORMET 18 14.9 CORMET/CORMET 2 4.4
ADEPT/ 
ADEPT
8 6.5 BHR/BHR 15 6.4 ICON TM/ICON TM 13 10.7 BHR/BHR 1 2.2
Conventional (stem/cup)
VERSYS/TRILOGY 210 10.5
VERSYS cim/
TRILOGY
358 9.3
FURLONG/CSF 
PLUS
305 5.7
FURLONG/CSF 
PLUS
450 7.7
FURLONG/CSF 
PLUS
410 7.9
VERSYS cim/ 
TRILOGY
158 7.9
VERSYS/ 
TRILOGY
356 9.3
VERSYS cim/ 
TRILOGY
277 5.2 UNITED U2/ U2 339 5.8 CORAIL/PINNACLE 276 5.3
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2005/2006 2007/2008 2009/2010 2011/2012 2013/2014
Model n % Model n % Model n % Model n % Model n %
FURLONG/FURLONG 136 6.8
UNITED U2/
UNITED U2
198 5.2
UNITED U2/
UNITED U2
270 5.0
VERSYS cim/
TRILOGY
246 4.2 VERSYS cim/TRILOGY 213 4.1
UNITED U2/
UNITED U2
134 6.7
SYMAX/ 
TRIDENT
152 4.0 VERSYS/TRILOGY 244 4.5 CORAIL/PINNACLE 235 4.0
NOVATION ELEMENT/
NOVATION CROWN
199 3.8
ECO cim/EXPANSYS 92 4.6 CORAIL/PINNACLE 110 2.9
CORAIL/
PINNACLE
236 4.4
EXETER cim/
CONTEMPORARY cim
195 3.3 UNITED U2/UNITED U2 164 3.2
Short stem (stem/cup)
MAYO/TRILOGY 1 50.0 PROXIMA/ASR 18 66.7
PROXIMA/
PINNACLE
47 37.6 PROXIMA/PINNACLE 51 33.6 ACCOLADE II/TRIDENT 45 22.8
PROXIMA/ASR 1 50.0
PROXIMA/
PINNACLE
7 25.9
C.F.P. LINK/
T.O.P. LINK
27 21.6
TAPERLOC 
MICROPLASTY/
EXCEED ABT
30 19.7
TAPERLOC 
MICROPLASTY/
BIHAPRO
23 11.7
PROXIMA/
REFLECTION SP3
1 3.7
C.F.P. LINK/
CFP-BETA CUP
25 20.0
MINIHIP/
TRABECULAR METAL
24 15.8 C.F.P. LINK/COMBICUP 21 10.7
PROXIMA/TRIDENT 1 3.7 PROXIMA/ASR 11 8.8
C.F.P. LINK/
T.O.P. LINK
15 9.9
FURLONG 
EVOLUTION/CSF PLUS
19 9.6
TAPERLOC 
MICROPLASTY/ 
EXCEED ABT
3 2.4
C.F.P. LINK/
COMBICUP
8 5.3
PROFEMUR 
PRESERVE/
PROCOTYL
13 6.6
Bipolar (stem/shell)
AUTOBLOQUEANTE 
cim/BIARTICULAR
57 16.8
AUTOBLOQUEANTE 
cim/BIARTICULAR
268 32.8
AUTOBLOQUEANTE 
cim/BIARTICULAR
354 21.9
AUTOBLOQUEANTE 
cim/BIARTICULAR
349 20.9
AUTOBLOQUEANTE  
cim/ BIARTICULAR
324 21.7
MULLER cim/UHR 
BIPOLAR
46 13.6
MAINSTREAM 
MULLER cim/
CAPTIVE
120 14.7
VERSYS cim/
MULTIPOLAR
138 8.5
KAREY cim/
MOONSTOONE
157 9.4
KAREY cim/
MOONSTOONE
177 11.9
MAINSTREAM 
MULLER cim/
CAPTIVE
45 13.3
VERSYS cim/
MULTIPOLAR
89 10.9
EXETER cim/
UHR BIPOLAR
107 6.6
VERSYS cim/
MULTIPOLAR
156 9.4
VERSYS cim/
MULTIPOLAR
129 8.7
ECO cim/CAPTIVE 35 10.3
EXETER cim/
UHR BIPOLAR
63 7.7
KAREY cim/
BIARTICULAR
85 5.3
SHINE-C cim/
BIARTICULAR
117 7.0
SHINE-C cim/
BIARTICULAR
124 8.3
VERSYS cim/
MULTIPOLAR
35 10.3 ECO cim/CAPTIVE 60 7.3 PMB cim/BIPOLAR 85 5.3
EXETER cim/UHR 
BIPOLAR
77 4.6
EXETER cim/
UHR BIPOLAR
107 7.2
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2005/2006 2007/2008 2009/2010 2011/2012 2013/2014
Model n % Model n % Model n % Model n % Model n %
Unipolar modular (stem/head)
ECO cim/HEMIHEAD 60 62.5 ECO cim/HEMIHEAD 88 66.7
AUTOBLQUEANTE 
cim/ENDOCEFÁLICA
75 32.5
AUTOBLOQUEANTE 
cim/ENDOCEFÁLICA
81 39.1
TWINSYS cim/
HEMIHEAD
34 29.8
ECO cim/S30 36 37.5
FULLFIX cim/
HEMIHEAD
43 32.6
CCM cim/
HEMIHEAD
56 24.2
TWINSYS cim/ 
HEMIHEAD
54 26.1
TAPERLOC cim/
BIOMET Head
30 26.3
MAINSTREAM 
MULLER cim/
BIOMET Head
1 0.8
FULLFIX cim/HEMI-
HEAD
45 19.5 CCM cim/HEMIHEAD 44 21.3
AUTOBLOQUEANTE 
cim/ENDOCEFÁLICA
22 19.3
CEMIRA cim/
HEMIHEAD
27 11.7
CEMIRA cim/
HEMIHEAD
25 12.1
TAPERLOC/
BIOMET Head
18 15.8
ECO cim/
BIOMET Head
21 9.1
WAGNER SL/
HEMIHEAD
2 1.0
MULLER cim/
ENDOCEFÁLICA
8 7.0
Unipolar monoblock (stem/manufacturer)
AUSTIN MOORE/
SURGIVAL C.O., S.A.
203 44.1
AUSTIN MOORE/
SURGIVAL C.O., 
S.A.
392 41.9
AUSTIN MOORE/
SURGIVAL C.O., 
S.A.
595 45.8
AUSTIN MOORE/
SURGIVAL C.O., 
S.A.
1,000 54.5
AUSTIN MOORE/
SURGIVAL C.O., S.A.
899 61.2
AUSTIN MOORE/ 
STRIKER IBERIA, SL
111 24.1
AUSTIN MOORE/
STRYKER IBERIA, 
SL
357 38.1
AUSTIN MOORE/
STRYKER IBERIA, 
SL.
518 39.9
AUSTIN MOORE/ 
STRYKER IBERIA, 
SL.
648 35.3
AUSTIN MOORE/ 
STRYKER IBERIA, 
SL.
450 30.6
THOMPSON cim/
SURGIVAL C.O., S.A.
76 16.5
THOMPSON cim/
SURGIVAL C.O., 
S.A.
84 9.0
THOMPSON/ 
STRYKER IBERIA, 
SL.
89 6.9
THOMPSON/ 
STRYKER IBERIA, 
SL.
98 5.3
THOMPSON/ 
STRYKER IBERIA, 
SL.
79 5.4
AUSTIN MOORE/
BIOMET
46 10.0
AUSTIN MOORE/
TRAIBER, S.L.
36 3.9
THOMPSON cim/
SURGIVAL C.O., 
S.A.
80 6.2
THOMPSON cim/
SURGIVAL C.O., 
S.A.
78 4.3
THOMPSON cim/
SURGIVAL C.O., S.A.
29 2.0
AUSTIN MOORE/
TRAIBER, S.L.
24 5.2
AUSTIN MOORE/
BIOMET
35 3.7
THOMPSON cim/ 
STRYKER IBERIA, 
SL.
7 0.5
THOMPSON cim/ 
STRYKER IBERIA, 
SL.
6 0.3
THOMPSON cim/
BIOMET
11 0.8
Percentages were calculated for each type of prosthesis out of total of prostheses used in each type of arthroplasty. Only the values of the 5 most common models are shown in 
the table, which explains that for some types of arthroplasties percentages do not add up to 100. 
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5.5. Implant survival in hip arthroplasties
Follow-up description
The median length of follow-up from the date of primary arthroplasty until the revision surgery 
or censorship was 3.93 years (SD: 2.42) and 3.71 years (SD: 2.28) for total and partial hip 
arthroplasties, respectively. Figure 23 shows the distribution of follow-up time for patients who 
underwent total and partial hip arthroplasty. 
Figure 23. Distribution of the follow-up time of patients undergoing a hip arthroplasty. A) Total arthroplasty; 
B) Partial arthroplasty. Source: RACat
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Cumulative revision rate
The estimated cumulative revision rate after a primary total and partial hip arthroplasty (with no 
adjustment) is shown in Table 46 and Table 47. For total hip arthroplasties, the cumulative revi-
sion rate at 1- year was 1.29%, rising to 2.99% at 5-year and 4.57% at 9-years after the primary 
surgery. For partial hip arthroplasties, the cumulative revision rates were 1.23%, 2.11%, and 
2.38% at 1-, 5- and 9-years after the primary surgery, respectively. 
Risk of revision both for patients undergoing total and partial hip arthroplasty was adjusted by 
sex, age, and comorbidities. As observed for knee arthroplasties, a higher risk of revision was 
observed in groups of younger patients. The Cox model fitted for total hip arthroplasties revealed 
a significant statistical risk of revision for patients under 65 years, patients between 65-75 years, 
and patients between 75-85 years compared to those aged 85 years or over (HR=2.87 (CI 95%: 
1.47-5.61); HR=2.38 (CI 95%: 1.22-4.65); HR= 1.96 (CI 95%: 1.00-3.84); data not shown). A 
similar trend was observed for partial hip arthroplasties for patients aged 65-75 years and 75-85 
years (HR=2.81 (CI 95%: 1.78-4.45; HR=1.63 (CI 95%: 1.21-2.20); data not shown). 
The cumulative revision rate by fixation technique (without adjustment) for total hip arthroplast-
ies revealed  relatively similar revision rates at different follow-up times. Cementless prostheses 
were those with the highest revision rates at 5- and 9-year of follow-up (3.11% and 5.05%, 
respectively) (Table 48, Figure 24). For partial hip arthroplasties, the cumulative revision rate for 
cemented prosthesis was 1.21% at 1-year follow up, and rose to 1.78% and 1.92% at 3- and 
5-year follow-up. For cementless prostheses the figures were 1.18%, 1.86% and 2.32% at 1-, 
3-, and 5-year of follow-up (Table 49). Risk of revision both for total and partial hip arthroplasties 
adjusted by sex, age and comorbidities and fixation technique revealed no differences in the risk 
of revision, age being the only factor associated with revision risk (data not shown). 
Table 50 shows the cumulative probabilities of revision per friction device for total hip arthroplas-
ties. Metal on metal prostheses showed revision rates of 1.98%, 3.61% and 5.49% at 1-, 3- and 
5- years of follow-up, whereas metal-polyethylene prosthesis presented slightly better out-
comes: 1.84%, 2.62% and 3.38%, respectively. The Cox model considering friction device 
(Metal on Polyethylene, Metal on Metal, Ceramic on Ceramic and Ceramic on Polyethylene) 
and adjusted by age, sex and comorbidities revealed an increased revision rate for Metal on 
Metal prosthesis in comparison to Metal on Polyethylene prosthesis (HR=1.43 CI 95%: 1.06-
1.93; data not shown).
We estimated the cumulative incidence of revision considering death as a competitive event, 
both for partial and total hip arthroplasties. Figure 25 shows two functions: one with the cumu-
lative risk of revision adjusted by age, sex, comorbidity and patient death probability, and the 
other adjusted by the same variables without considering the competitive risk of death. For total 
hip arthroplasties, both curves are quite similar, the cumulative incidence function without 
adjustment by competitive risk of death slowly growing apart from the other curve. The cumula-
tive incidence of revision, adjusted by age, sex, and comorbidity at 5 years was 3.20% and 
considering competitive risk of death, 3.15%. However, for partial knee arthroplasties differ-
ences are greater, especially after 2-3 years of follow-up. The cumulative incidence of revision, 
adjusted by age, sex, and comorbidity at 5 years was 2.36% and considering competitive risk of 
death 2.05%.
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Table 46. Estimated cumulative revision rate after a primary total hip arthroplasty. Source: RACat-MBDSHD-
RCA
Time Primary Revisions
Cumulative 
Revision Rate 
(%)
CI 95%
30 days 20,654 79 0.38 0.30 0.47
90 days 20,106 97 0.85 0.73 0.99
1 year 18,253 85 1.29 1.14 1.45
3 years 12,378 142 2.18 1.98 2.40
5 years 6,600 80 2.99 2.72 3.28
7 years 2,775 42 3.88 3.51 4.28
9 years 306 12 4.57 4.03 5.17
CI 95%: 95% confidence interval. RACat: Catalan Arthroplasty Register
Table 47. Estimated cumulative revision rate after a primary partial hip arthroplasty. Source: RACat- MBD-
SHD-RCA
Time Primary Revisions
Cumulative 
Probability of 
revision
CI 95%
30 days 10,949 46 0.42 0.31 0.56
90 days 10,684 57 0.94 0.78 1.14
1 year 9,717 30 1.23 1.04 1.46
3 years 6,319 51 1.82 1.57 2.10
5 years 2,969 15 2.11 1.83 2.43
7 years 1,154 1 2.18 1.87 2.54
9 years 114 1 2.38 1.92 2.95
CI 95%: 95% confidence interval. RACat: Catalan Arthroplasty Register
Estimates in italics indicate that fewer of 250 remain at risk of revision at the time shown. Blank cells indicate that the 
number at risk at the time shown is fewer than 100 cases. In that case, estimates were not calculated since they are 
very unreliable.
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Table 48. Estimated cumulative revision rate after a primary total hip arthroplasty by fixation technique. 
Source: RACat- MBDSHD-RCA
Time Primary Revisions
Cumulative 
Revision Rate 
(%)
CI 95%
Cemented
30 days 2,049 12 0.58 0.33 1,02
90 days 2,000 12 1.17 0.78 1.74
1 year 1,870 6 1.47 1.03 2.10
3 years 1,258 11 2.12 1.56 2.87
5 years 730 6 2.69 2.00 3.60
7 years 380 3 3.25 2.38 4.44
9 years 66 0 . . .
Cementless
30 days 13,563 45 0.33 0.25 0.44
90 days 13,167 67 0.83 0.69 0.99
1 year 11,826 56 1.27 1.09 1.47
3 years 7,894 89 2.12 1.88 2.40
5 years 4,039 62 3.11 2.77 3.49
7 years 1,553 30 4.17 3.68 4.73
9 years 158 8 5.05 4.28 5.95
Hybrid 
30 days 4,387 19 0.43 0.27 0.67
90 days 4,292 17 0.82 0.59 1.13
1 year 3,953 20 1.30 1.00 1.68
3 years 2,775 38 2.42 1.98 2.96
5 years 1,583 9 2.85 2.34 3.47
7 years 770 9 3.60 2.92 4.43
9 years 71 4 . . .
Inverse Hybrid 
30 days 636 3 0.47 0.15 1.45
90 days 630 1 0.63 0.24 1.66
1 year 593 3 1.10 0.53 2.30
3 years 449 4 1.86 1.03 3.34
5 years 250 3 2.69 1.56 4.60
7 years 75 0 . . .
9 years 13 0 . . .
CI 95%: 95% confidence interval. RACat: Catalan Arthroplasty Register
Estimates in italics indicate that fewer of 250 remain at risk of revision at the time shown. Blank cells indicate that 
the number at risk at the time shown is fewer than 100 cases. In that case, estimates were not calculated since they 
are very unreliable.
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Table 49. Estimated cumulative revision rate after a primary partial hip arthroplasty by fixation technique. 
Source: RACat
Time Primary Revision
Cumulative 
Revision Rate 
(%)
IC95%
Cemented
30 days 5,420 24 0.44 0.30 0.66
90 days 5,286 32 1.03 0.79 1.34
1 year 4,839 13 1.28 1.01 1.62
3 years 3,306 22 1.78 1.45 2.18
5 years 1,531 4 1.92 1.57 2.36
7 years 579 1 2.06 1.64 2.60
9 years 67 1 . . .
Cementless
30 days 5,527 22 0.40 0.26 0.60
90 days 5,396 25 0.85 0.64 1.13
1 year 4,877 17 1.18 0.92 1.50
3 years 3,013 29 1.86 1.52 2.28
5 years 1,438 11 2.32 1.90 2.84
7 years 576 0 2.32 1.90 2.84
9 years 48 0 . . .
CI 95%: 95% confidence interval. RACat: Catalan Arthroplasty Register
Estimates in italics indicate that fewer of 250 remain at risk of revision at the time shown. Blank cells indicate that the 
number at risk at the time shown is fewer than 100 cases. In that case, estimates were not calculated since they are 
very unreliable.
Figure 24. Cumulative risk of revision after a total hip arthroplasty by fixation technique. Source: RACat- 
MBDSHD-RCA
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Table 50. Estimated cumulative revision rate after a primary total conventional hip arthroplasty per friction 
device. Source: RACat
Time Primary Revision
Cumulative 
Revision Rate 
(%)
CI 95%
Metal on Metal
30 days 970 6 0.61 0.27 1.35
90 days 936 9 1.54 0.93 2.54
1 year 864 4 1.98 1.27 3.09
3 years 687 13 3.61 2.56 5.08
5 years 420 11 5.49 4.06 7.4
7 years 134 6 7.42 5.48 10.01
9 years 12 1
Metal on polyethylene
30 days 13448 113 0.83 0.69 1
90 days 13139 83 1.45 1.26 1.66
1 year 12111 50 1.84 1.62 2.08
3 years 8489 85 2.62 2.35 2.92
5 years 4761 53 3.38 3.05 3.74
7 years 2109 30 4.25 3.8 4.74
9 years 219 7 4.72 4.16 5.35
Ceramic on Polyethylene
30 days 2413 7 0.29 0.14 0.6
90 days 2343 2 0.37 0.19 0.71
1 year 2096 13 0.95 0.63 1.45
3 years 1401 18 1.94 1.42 2.64
5 years 760 7 2.58 1.91 3.47
7 years 318 3 3.14 2.28 4.32
9 years 52 4
Ceramic on Ceramic
30 days 1664 5 0.3 0.12 0.71
90 days 1617 3 0.48 0.24 0.96
1 year 1456 8 0.99 0.61 1.62
3 years 763 13 2.06 1.42 2.97
5 years 282 6 3.19 2.19 4.64
7 years 112 3 4.78 3.03 7.51
9 years 26 0
CI 95%: 95% confidence interval. RACat: Catalan Arthroplasty Register
Estimates in italics indicate that fewer of 250 remain at risk of revision at the time shown. Blank cells indicate that the 
number at risk at the time shown is fewer than 100 cases. In that case, estimates were not calculated since they are 
very unreliable.
The number of patients at risk for the other fixation categories was <100; the estimates were not calculated since they 
were very unreliable.
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Figure 25. Cumulative incidence of revision after a partial hip arthroplasty adjusted by competitive risk of 
death, age and sex. A) Total hip arthroplasty; B) Partial hip arthroplasty. Source RACat-RCA
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6. Discussion
The results presented in this report provide an overview of the continued improvement of the 
Catalan Arthroplasty Register (RACat) regarding the volume and quality of the data. We also 
report the characteristics of patients undergoing hip and knee arthroplasty, as well as implant 
characteristics and prosthesis survival considering the procedures carried out between 2005 
and 2014 in Catalonia. 
6.1. Quality of the data: volume of interventions and completeness
Following a steady rise in the number of hip and knee cases reported to the RACat as of  2005, 
the data demonstrates a decrease  between  2010 and 2011. This decrease was linked to a reor-
ganisation of hospital care carried out in Catalonia that year, given that once this had finished in 
2012, the number of interventions being reported to the register started to gradually rise again. 
However, the increase in the number of arthroplasties in the last year was not reflected in the 
data sent to the RACat. This was due to the fact that, at the end of 2013, hospitals had to tem-
porarily stop their data notifications in order to adapt their IT systems to the technical require-
ments of the Catalan Health Service (CHS), which included a new web services communication 
process. This is the reason why RACat completeness values also decreased during the latter-
period (2013-2014). Nevertheless, they can be expected to improve as a result of the satisfac-
tory resolution of this circumstance. 
Even with the improvement of completeness and the quality of the data, further  strategies must 
be designed to  allow even greater improvement to continue. The participation of private centres 
will be essential in order to have a complete picture of the healthcare assistance activity in 
 Catalonia.
6.2. Description of patients and the healthcare process
Confirming trends observed in previous reports and in other countries3,4,10-12, the current results 
show that both knee and hip arthroplasties were more frequently preformed among women than 
among men, osteoarthritis being by far the most prevalent reason for intervention in total hip and 
both total and partial knee arthroplasties. Meanwhile, mechanical complications of orthopaedic 
devices were the main reason for revision, a situation that had already been observed in other 
European registers, which reported aseptic loosening as the main cause for revision3. In the 
RACat, aseptic loosening was analysed together with other diagnoses such as dislocation and 
contact surface wear, under the concept of mechanical complications. 
Results pointed out that the majority of patients undergoing hip and knee arthroplasties pre-
sented one or more comorbidities. This may be related to increased life expectancy and to 
improvements in surgical techniques, which have made it possible to operate on older patients, 
who tend to have a higher number of comorbidities. However, some specific comorbidities such 
as obesity, renal failure and neurological disorders, have been highlighted as  obstacles in the 
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recovery process, since these patients will be less likely to increase their physical activity after 
elective surgery13. 
Regarding the type of discharge from hospital, the most common destination was home. 
Although this appears to be better in terms of early recovery14, patient satisfaction and health-
care costs, there is no clear evidence regarding the impact it might have on the long-term recov-
ery process15. For this reason, it may be interesting for future studies to look at potential 
readmissions of patients per their discharge type, in order to obtain more evidence on the 
healthcare quality of this practice after an arthroplasty.
6.3. Characteristics of primary arthroplasties and implant models
Our findings revealed significant variability in the number of prosthesis models used depending 
on the hospital, both for knee and hip arthroplasties. Some studies suggested that using a high 
number of models could be a risk factor for revision16. Based on the results of the Swedish reg-
ister, this group recommends limiting the number of models in use, with expectations of reduc-
ing the risk of revision. This measure, if confirmed, could be of interest for Catalonia, given the 
wide variability observed in our hospitals. Further analyses aimed at exploring the specific 
results of implant models would facilitate the decision-making process for professionals based 
on reliable clinical evidence. Some initiatives, such as the Orthopaedic Data Evaluation Panel 
(ODEP)17 in the UK, or the Dutch Hip Task Force (DHTF)18 in The Netherlands, provide on-going 
assessment of hip and knee implants presenting a benchmark rating for implant survival.
In accordance with trends observed in the latter period, the most common knee procedure was 
total knee arthroplasty. Although the number of partial arthroplasties has increased slightly dur-
ing the most recent periods, their impact on overall knee procedures remains low. In the case of 
primary hip arthroplasties, the number of partial procedures has increased. For this kind of sur-
gery, we observed a decreasing trend over time on the use of unipolar monoblock and an 
increase of bipolar prosthesis. This pattern was also observed in Australia19 but contrasts with 
trends reported in Sweden11. 
Regarding the type of fixation, RACat recorded an increase in the volume of primary cemented 
knee arthroplasties, confirming trends observed in latter periods. On the contrary, most of total 
hip arthroplasties were cementless, this type of fixation showing an increasing trend over time, 
especially among young patients. This pattern is consistent with trends reported in other coun-
tries like Norway20, Sweden11, New Zealand21, and the United Kingdom22. Likewise, the use of 
metal on metal as bearing surface has decreased over time, whereas metal-polyethylene is 
increasingly used. 
6.4. Implant survival
In general, both knee and hip arthroplasties presented good implant survival, both in the short, 
medium, and long-term. Total knee arthroplasties showed better survival outcomes than partial 
replacements. In particular, tour finding show  a 9-year revision rate less than 4% for cemented 
and hybrid prosthesis, this data being in accordance with that reported in other countries22. Uni-
compartmental replacements showed worse survival results compared to total knee replace-
ments with the chance of revision at each estimation time point being around twice  that of a 
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total knee replacement. It has to be considered that this surgery has different indications than 
total knee arthroplasty, being more commonly performed among younger patients. This may be 
related to milder disease in these patients, or the desire to delay a total knee replacement for as 
long as possible. Moreover, younger patients may also be more active and are more likely to 
present better health conditions, which puts more strain on their implants and allows reoperation 
if a complication or failed prosthesis occurrs. 
Following trends observed in previous reports, partial hip arthroplasties presented better sur-
vival outcomes than total hip procedures. Again, differences in patient’s age may explain the 
different results, given that partial arthroplasties are more commonly performed in older patients, 
as an indication of femoral neck fracture. 
As expected, metal on metal implants showed significantly higher revision rates in comparison 
to other friction devices, confirming in our setting the unsatisfactory results of these bearing 
devices in the medium- and long-term reported in the literature23. This situation calls for close 
surveillance of patients with this kind of prosthesis and for monitoring the degree of accomplish-
ment of recommendations issued by public bodies. In parallel, current data points out that 
ceramic–metal implants presented the lowest failure rates, followed by metal-polyethylene 
implants.
6.5. Strengths and weaknesses
After 10 years of implementation of the RACat, current data provides us with  an overall  picture 
of the performance of hip and knee arthroplasties in Catalonia as well as robust estimators on 
implant utilization and survival outcomes. However, we would like to pint out  certain limitations 
that should be taken into consideration when interpreting the results presented herein. Firstly, 
the volume of cases in some subgroups remains low, especially in the survival analyses. This 
situation hampers the calculation of risk of revision in the medium- and long-term. As a result, 
long-term survival outcomes for some figures should be interpreted with caution. 
Secondly, we wish to point out the high number of cases in which the type of fixation was not 
specified, most notably in the earlier years of the register. During this period,  the emphasis was 
on the implementation of the register, without as much emphasis being placed on the quality of 
the data as there is now. It is hoped that in coming years the percentage of cases not reported 
to the RACat will gradually decrease, as has been the trend to date. Finally, as we have already 
mentioned above, the information on cause for revision was obtained by merging our database 
with the MBDSHD. As pointed out, there are some deficiencies in the MBDSHD coding that 
hamper the level of detail of this variable. We do believe that with the implementation of the 
surgical form, we will overcome this limitation, given that this form will allow us to collect more 
accurate information regarding this variable along with other clinical information. 
Despite the limitations mentioned above and the difficulty and high cost involved in implement-
ing and maintaining a register of this kind, we can assert that the RACat has consolidated itself 
as a powerful tool for analysing the medium- and long-term effectiveness of hip and knee arthro-
plasties, for studying the variability of clinical practice, and for post-market monitoring.
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7. Final Remarks and Next 
Steps
7.1. Latest achievements
Year after year we stress our commitment to improve the quality of the Register and to publicize 
the results and the potential of this tool for managers, surgeons and healthcare professionals. 
In this line, we would like to highlight some of the activities and products that have been released 
over the last year. 
Commemoration of the 10th anniversary of the RACat. A  multidisciplinary, informative ses-
sion was organised in conjunction with the Catalan Society of Orthopaedic Surgery and Trau-
matology (SCCOT). Experts from different fields of health care, management, research, industry, 
and administration were invited, with the aim of pooling knowledge and perspectives on the 
scope and implications of the RACat. These different points of view, along with the patient’s 
vision, were recorded in an educational video, which is available on our website: http://aquas.
gencat.cat/ca/projectes/mes_projectes/qualitat_atencio_sanitaria/racat/
Atlas of Variation of Knee and Hip Arthroplasties in Catalonia. As part of a wider project 
lead by the Agency for Health Quality and Assessment (AQuAS), Atlases of Variations in Knee 
and Hip Arthroplasties in Catalonia were presented using an interactive format. This new format, 
which uses the InstantAtlas Dynamic Report Platform, allows us to view data from different 
basic healthcare areas in Catalonia and to benchmark the performance of both surgeries over 
different time periods. These arealso available on our website: http://aquas.gencat.cat/ca/pro-
jectes/atles-de-variacions-i-de-qualitat-del-siscat/atles_variacions/atles_finalitzats/atles_gen-
oll/atles_digital_artroplasties_genoll_maluc/
Research. The RACat is also involved in several research projects lead by clinicians, epidemi-
ologists, and healthcare professionals, which explore different issues related to arthroplasties 
performance and its impact on the healthcare system. 
7.2. Next steps
For the upcoming years, we face new challenges that we are sure will contribute to improving 
the quality of the register and will promote the visualization and utilization of the RACat. 
Implementation of the surgical form. The inclusion of variables from the surgical form will 
substantially increase the information recorded in the register (mainly clinical information), 
enriching the current dataset and enhancing the possibility to refine some analyses. Although 
some hospitals are currently reporting the variables of this form, there is still room for improve-
ment in its complete implementation in Catalonia.  
Data from private centres. The current scope of the register includes hospitals run by the Inte-
grated Healthcare System of Public Healthcare Network of Catalonia (SISCAT). Widening the 
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scope to private and public centres will enable us to get  a complete picture of the arthroplasties 
carried out in Catalonia (reaching 100% coverage) and will enable the monitoring and surveil-
lance of all prosthesis used in our country. 
Continuous improvement of data quality. We are still making efforts to improve the quality of 
the information sent by centres. We periodically perform data quality reviews, schedule face-to-
face meetings with centres, and promote close collaboration with professionals. However, the 
best way to promote and encourage participation is to make the register more useful for profes-
sionals according to their needs. This is one of the main challenges we face. 
Linking the RACat with different databases. In recent years, we have carried out ad-hoc 
linkages with databases in order to answer specific research questions arising out ofdifferent 
projects. This has enabled collaborations with researchers from other disciplines and has 
enhanced the possibilities of data exploitation. We hope to consolidate past collaborations and 
to initiate new projects. 
Promote dissemination. Participation in scientific forums and international networks will pro-
mote the visualization and dissemination of the RACat both inside Catalonia and beyond our 
borders. In this line, we have planned to improve the information displayed on our website to 
make it more attractive, visual, and current.
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